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ABSTRACT 
ABSTRACT 
NF-κB is a transcription factor involved in the regulation of inflammation and 
innate immunity. The IκB kinase (IKK) complex contains two catalytic subunits, IKKα 
and IKKβ, and plays an essential role in the activation of NF-κB through the 
phosphorylation and degradation of the NF-κB inhibitor IκBα, thereby allowing 
translocation of NF-κB into the nucleus. Numerous evidences indicate that IKKβ 
mediates NF-κB activation in response to pro-inflammatory cytokines and microbial 
products, but the role of IKKα in inflammation and innate immunity is unknown.  
In the first part of dissertation, we focus on understanding the previously 
unknown function of IKKα in the canonical NF-κB pathway, associated with 
inflammation and innate immunity. We show that silencing of IKKα by RNA 
interference (RNAi) significantly reduced phosphorylation and degradation of IκBα, 
and nuclear translocation of NF-κB, and secretion of the pro-inflammatory chemokine 
interleukin-8 (IL-8) during Shigella flexneri infection of human epithelial HeLa cells. 
This suggests that IKKα like IKKβ plays a pivotal role in inflammation and innate 
immunity by mediating NF-κB activation in response to microbial infection.  
Proper control of NF-κB activation is essential for inflammation and innate 
immunity triggered by microbial infection, but the dysregulation of NF-κB is associated 
with various diseases such as chronic inflammatory diseases and cancers. Thus, the NF-
κB pathway has been a target of therapeutic drug development. Although constitutive 
and excessive NF-κB activation has been detected in many inflammation-related 
diseases, the cause of the constitutive NF-κB activation in non-stimulated cells is 
largely unknown. 
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ABSTRACT 
In the second part of dissertation, we focus on clathrin heavy chain (CHC), a 
well-known regulator of endocytosis that plays a novel endocytosis-independent 
function as an inhibitor of basal NF-κB activation. We show that silencing of CHC 
induced constitutive NF-κB nuclear translocation and high level of IL-8 secretion in 
resting cells. We revealed that constitutive NF-κB nuclear translocation was mediated 
through the constant IκBα degradation in an IKKα-dependent mechanism. We further 
showed that CHC depletion-induced constitutive IκBα degradation and high level of IL-
8 secretion in resting cells was independent of the inhibition of clathrin-mediated 
endocytosis (CME) as silencing of μ2 subunit of AP2 complex (AP2M1), an adaptor 
protein essential for CME failed to induce the constitutive IκBα degradation and high 
level of IL-8 secretion. Therefore, the results presented may suggest a potential link 
between a defect in CHC expression and chronic inflammatory disorders and cancers. 
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CHAPTER 1 
GENERAL INTRODUCTION 
1.1 The transcription factor NF-κB 
1.1.1 NF-κκB and IκB proteins  
Nuclear factor kappa-B (NF-κB) was originally discovered by Sen and Baltimore in 1986 
as a transcription factor present in activated B-cells that strongly activates the 
immunoglobulin κB light chain gene expression (Sen and Baltimore 1986). 25 years of 
research on NF-κB has revealed that this transcription factor plays important roles in 
diverse physiological responses including inflammation, adaptive immunity, cell adhesion, 
cell growth, differentiation, oxidative stress responses and apoptosis (Gilmore 2006). Not 
surprisingly, dysregulation of NF-κB has been implicated in an ever-expanding list of 
diseases such as Crohn’s disease, arthritis, diabetes and cancers (Lawrence 2009).  
There are five known members of the mammalian NF-κB/Rel family forming 
various homo- and hetero-dimers: RelA (p65), RelB, c-Rel, NF-κB1 (p105/p50), and NF-
κB2 (p100/p52) (Figure 1.1)  (Ghosh and Hayden 2008). All the NF-κB proteins share a 
highly conserved Rel-homology domain (RHD) for dimerization, nuclear localization, and 
DNA binding. The Rel proteins (RelA, RelB and c-Rel) contain C-terminal transactivation 
domains. NF-κB1 (p105/p50) and NF-κB2 (p100/p52) are distinguished by their long C-
terminal domains that contain multiple copies of ankyrin repeats, which act to inhibit these 
proteins. NF-κB1 (p105/p50) and NF-κB2 (p100/p52) become shorter and active DNA-
binding proteins (p105 to p50 and p100 to p52) by limited proteolysis (Fan and Maniatis 
1991; Betts and Nabel 1996). The processing of p105 and p100 is mediated by the 
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ubiquitin-proteasome pathway and involves selective degradation of their C-terminal 
region containing ankyrin repeats (Fan and Maniatis 1991; Betts and Nabel 1996). Glycine-
rich region (GRR) provides the stop signal for processing of p105 and p100 (Lin and 
Ghosh 1996; Heusch, Lin et al. 1999). The most abundant form of NF-κB is the 
heterodimer of RelA (p65) and p50, retained in the cytoplasm through interaction with IκB 
proteins, which masks nuclear localization signal (NLS) of NF-κB proteins (Jacobs and 
Harrison 1998).  
The IκB (NF-κB inhibitor) proteins include IκBα, IκBβ, IκBε, IκBζ, Bcl-3, IκBNS 
(NF-κBδ),  and the NF-κB precursors p100 and p105 (Figure 1.1) (Ghosh and Hayden 
2008). All IκBs contain five to seven ankyrin-repeats mediating the binding to the RHD 
masking the nuclear localization signal (NLS) of NF-κB. The best-characterized IκB 
proteins is IκBα, composed of three regions: an N-terminal region, which regulates signal-
dependent degradation; an ankyrin repeat domain; and a C-terminal PEST region 
regulating basal degradation. Nearly all of the NF-κB is bound to IκBα, resulting in near-
complete inhibition of nuclear localization and transcriptional activation (Ferreiro and 
Komives). 
  2
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Figure 1.1. NF-κB and IκB protein families. Domains for each protein family are shown. The 
precursor proteins p100 and p105 function as both IκB proteins and, when processed by the 
proteasome, NF-κB family members. ANK, ankyrin-repeat; BCL-3, B-cell lymphoma 3; DD, death 
domain; GRR, glycine-rich region; PEST, proline-, glutamic acid-, serine- and threonine-rich; RHD, 
REL homology domain; TAD, transactivation domain. Adapted from Ghosh and Hayden 2008 
(Ghosh and Hayden 2008) 
 
1.1.2 Canonical and non-canonical NF-κB signaling pathways   
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With the exception of mature B cells where they are constitutively nuclear, in all other cell 
types NF-κB dimers are present in the cytoplasm through association with the IκBs as 
inactive forms (Liou and Baltimore 1993). Activation of NF-κB (usually assessed by the 
presence of nuclear NF-κB)  is induced by diverse extracellular stimuli including 
inflammatory cytokines such as tumor necrosis factor alpha (TNFα) and interleukin-1 (IL-
1), receptor ligands such as CD40-ligand, physical stress such as ultraviolet (UV) 
irradiation, and many bacteria and viruses (Pahl 1999). The active NF-κB promotes the 
expression of hundreds of target genes including cytokines, chemokines, cell adhesion 
molecules, stress response genes, and the regulators of apoptosis [nf-kb.org]. A key step for 
controlling NF-κB activity is the regulation of the NF-κB- IκBα interaction.  
There are at least two separate pathways for NF-κB activation; the canonical and 
noncanonical pathway (Gilmore 2006; Lawrence 2009). The canonical (or classical) 
pathway is triggered by proinflammatory cytokines such as TNFα and IL-1, and microbial 
products such as lipopolysaccharide (LPS) and peptidoglycan (PGN), and is associated 
with inflammation. In the canonical pathway, NF-κB (for example, the RelA (p65)/p50 
complex) activation is mediated by IKK complex, especially IKKβ and NEMO/IKKγ, 
dependent phosphorylation and degradation of IκBs (Figure 1.2) (Karin and Ben-Neriah 
2000). In contrast, the noncanonical pathway depends on IKKα-dependent processing of 
the p100 precusor into p52 and subsequent activation of RelB/p52 complex (Dejardin 
2006; Lawrence and Bebien 2007).  The noncanonical (or alternative) pathway is activated 
by TNF-family cytokines including lymphotoxinβ (LT or TNFSF3), CD40 ligand (CD40L 
or TNFSF5), B cell activating factor (BAFF or TNFSF13B), and receptor activator of NF-
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κB ligand (RANKL or TNFSF11), and is important in lymphoid organogenesis and B-cell 
development (Gerondakis and Siebenlist).  
Canonical pathway Non-canonical pathway
 
 
Figure 1.2 Canonical and noncanonical NF-κB pathways. The canonical pathway is triggered by 
TLRs and proinflammatory cytokines such as TNFα and IL-1, leading to activation of RelA that 
regulates expression of proinflammatory and cell survival genes. The noncanonical NF-κB pathway 
is activated by LTβ, CD40L, BAFF, and RANKL, but not TNFα, and results in activation of 
RelB/p52 complexes. Activation of the alternative pathway regulates genes required for lymph-
organogenesis and B-cell activation. These pathways are characterized by the differential 
requirement for IKK subunits. IKKβ regulates activation of the canonical pathway through 
phosphorylation of IκBs and requires the IKKγ subunit but not IKKα, whereas IKKα is required 
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for activation of the non-canonical pathway through the phosphorylation and processing of p100, 
the precursor for p52, but this is independent of both IKKβ and IKKγ. Adapted from Lawrence T. 
Cold Spring Harb Perspect Biol 2009 (Lawrence 2009). 
 
1.1.3 Mechanisms of IKK complex activation and inhibition   
The IKK complex is composed of at least two highly homologous kinase subunits, IKKα 
/CHUK and IKKβ, and a regulatory subunit IKKγ/NEMO (NF-κB essential modulator) 
(Figure 1.3) (Hacker and Karin 2006). Based on mutational analyses, it is generally 
believed that IKKβ and NEMO are essential for IκBα phosphorylation and degradation in 
most canonical NF-κB signalling pathways, whereas IKKα is dispensable in the canonical 
pathway, but is essential for p100 phosphorylation and processing to p52 in the non-
canonical pathway. In addition to the core IKK components IKKα, IKKβ, and NEMO, 
additional subunits are reported to associate with the IKK complex. HSP-90/Cdc37 
functions as a chaperone during assembly of the IKK complex upon stimulation (Hinz, 
Broemer et al. 2007). The HSP-90 inhibitor geldanamycin has been shown to inhibit 
activation of IKK by TNFα (Lewis, Devin et al. 2000). ELKS is reported to be associated 
with IKK complex as a regulatory component like NEMO (Ducut Sigala, Bottero et al. 
2004).  
IKKα and IKKβ dimerize through the leucine zipper domain, which is also required 
for kinase activity (Mercurio, Zhu et al. 1997; Woronicz, Gao et al. 1997; Zandi, Rothwarf 
et al. 1997). IKKα and IKKβ bind NEMO through the C-terminal NEMO-binding domain 
(NBD) (Figure 1.4) (Hayden and Ghosh 2008). The N-terminal coiled-coil motif of NEMO 
is responsible for the interaction with IKKα and IKKβ (Drew 2007).  Activation of IKK 
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complex requires NEMO oligomerization and serine 177 and serine 181 phosphorylation of 
IKKβ within the activation loop (T loop). IKKα is similarly phosphorylated on serine 
residues 176 and 180. An enforced NEMO oligomerization leads to IKK activation 
(Inohara, Koseki et al. 2000; Poyet, Srinivasula et al. 2000). Mutation of the activation loop 
serines to glutamic acid makes IKK constitutively active, while mutation to alanines 
abrogates downstream signal transduction (Hacker and Karin 2006). In the resting state, the 
IKK complex is held inactive through its interaction with NEMO. Upon stimulation, 
NEMO undergoes ubiquitination and oligomerization, which induces a conformational 
change that leads to the exposure of kinase domain and T loop serines on IKKα and IKKβ, 
thereby allowing transautophosphorylation or T-loop serine phosphorylation by upstream 
kinases such as TAK1 (Hayden and Ghosh 2008).   
 
 
 
 
 
Figure 1.3 The IKK Protein Family. Members of the IKK proteins are shown. The number of amino 
acids in each human protein is indicated on the right. Posttranslational modifications that influence 
IKK activity or transcriptional activation are indicated with P or Ub for phosphorylation or 
ubiquitination, respectively. LZ, leucine zipper domain; HLH, helix-loop-helix domain; NBD, 
NEMO-binding domain; CC1/2, coiled-coil domains; Z, zinc finger domain. Adapted from Hayden 
and Ghosh 2008 (Hayden and Ghosh 2008). 
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Activation of IKK activity is a transient event, requiring negative feedback 
regulation. It was shown that phosphorylation of the NBD at serine 740 in IKK intrinsically 
inhibits IKK activity (May, D'Acquisto et al. 2000). In addition, active IKK can 
phosphorylate serine 68 within the IKK-binding domain of NEMO, which disrupts the 
interaction between IKK and NEMO, thereby terminating signalling (Palkowitsch, Leidner 
et al. 2008). The serine 68 phosphorylation in NEMO and serine 740 phosphorylation in 
IKKβ allows dephosphorylation of serines in the T-loops by PP2A or PP2Cβ, resulting in 
reconstitution of a signalling-competent IKK complex through Cdc37/HSP-90-mediated 
chaperone activity (Figure4) (Kray, Carter et al. 2005; Palkowitsch, Leidner et al. 2008).  
Resting state
Exposure of Ser residues 
to IKK kinases
Active state
Inactivation
Activation
 
 
 
 
 
 
 
 
 
Figure 1.4 A putative model for IKK activation. In the resting state, activation of IKKα and IKKβ is 
prevented by binding to NEMO. Conformational changes in the IKK complex induced by binding 
of NEMO to RIP, and/or ubiquitination of NEMO, lead to the exposure of the IKK kinase domain 
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and T loop serines and consequent transautophosphorylation or phosphorylation by an IKK-K such 
as TAK1. The active IKK then phosphorylates downstream substrates, including serine 740 within 
the IKK NBD and serine 68 in NEMO. NEMO phosphorylation results in the separation of stable 
NEMO dimers and NEMO binding to IKK. Dephosphorylation of the IKK T loop results in kinase 
inactivation, whereas phosphorylation of the IKK NBD and NEMO serine 68 prevents reactivation 
of the kinase. Cdc37/ HSP-90-mediated chaperone activity and PP2A and PP2Cβ phosphatase 
activity may then mediate regeneration of the IKK complex. Adapted from Hayden and Ghosh 
2008 (Hayden and Ghosh 2008). 
  
1.1.4 Activation of the NF-κB pathway by ubiquitin signaling  
Ubiquitination is a reversible covalent modification by which ubiquitin is attached to a 
target protein through an isopeptide bond between the C-terminus of ubiquitin and the ε-
amino group of a lysine residue in the target protein (Pickart and Eddins 2004). This 
process is catalyzed by three enzymatic steps via an ubiquitin-activating enzyme (E1), an 
ubiquitin-conjugating enzyme (E2 or UBC), and an ubiquitin-protein ligase (E3). Ubiquitin 
contains seven lysine residues that can be attached to other ubiquitins to form a 
polyubiquitin chain (Pickart and Eddins 2004).  
A polyubiquitin chain linked through lysine 48 (Lys-48) of ubiquitin targets a 
protein for degradation by the proteasome (Pickart and Eddins 2004). This ubiquitin-
proteasome pathway is responsible for the degradation of the NF-κB inhibitor IκBα in the 
canonical NF-κB signaling pathway or the processing of p100 in the non-canonical 
pathway (Figure 1.5) (Alkalay, Yaron et al. 1995; Chen, Hagler et al. 1995; Skaug, Jiang et 
al. 2009). In response to cytokines such as TNFα, IκBα is phosphorylated by IKKα/β at 
two serine residues near the N-terminus (Ser-32 and Ser-36) (DiDonato, Mercurio et al. 
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1996; DiDonato, Hayakawa et al. 1997) and is then ubiqutinated by an E2 of the UBC4/5 
family and the SCFβ-TrCP E3 ligase complex (Skp1-Cdc53/Cullin1-F-box ligase containing 
the β transducin repeat-containing protein β-TrCP) (Spencer, Jiang et al. 1999; Winston, 
Strack et al. 1999).  The polyubiquitinated IκBα is then selectively degraded by the 26S 
proteasome (Chen, Hagler et al. 1995).  
Figure 1.5 Degradation or processing of IκBα proteins by Lys48-linked ubiquitination. In canonical 
NF-κB activation (left), stimulation of the TNF receptor (TNFR), IL-1 receptor (IL-1R), and Toll-
like receptors (TLRs) leads to activation of the TAK1 complex through TRAF proteins. TAK1 then 
activates IKK, which in turn phosphorylates IκB proteins and targets them for polyubiquitination by 
the SCF-βTrCP E3 ligase complex. Ubiquitinated IκB is degraded by the proteasome, allowing the 
p50/p65 NF-κB dimer to enter the nucleus and activate gene transcription. In noncanonical NF-κB 
activation (right), stimulation of a subset of receptors, including the BAFF receptor, leads to the 
stabilization of the kinase NIK, followed by activation of IKKα. IKKα phosphorylates p100, 
leading to its ubiquitination by the SCF-βTrCP complex. Ubiquitinated p100 is targeted for 
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proteasomal processing to p52. The p52/REL-B dimer then translocates into the nucleus to activate 
gene transcription. 
 
On the other hand, a polyubiquitin chain linked through lysine 63 (Lys-63) of 
ubiquitin does not target a protein for degradation by the proteasome, but it plays a crucial 
role in the regulation (both activation and inhibition) of diverse NF-κB signaling pathways 
(Chiu, Zhao et al. 2009). The IKK complex integrates signals from diverse pathways to 
activate NF-κB (Solt and May 2008). TRAF (TNFR-associated factor) family of ubiquitin 
E3 ligases play an essential role in the activation of the IKK complex by many cell-surface 
receptors, including TNF receptor (TNFR) superfamily, the IL-1 receptor (IL-1R) and Toll-
like receptors(TLRs) (Bradley and Pober 2001; Chung, Park et al. 2002). Binding of 
interleukin-1β (IL-1β) to IL-1R or LPS to TLR4 causes recruitment of MyD88, IRAK, and 
TRAF6 to the receptor. Auto-K63 polyubiquitination of TRAF6 facilitated by 
Ubc13/Uev1A (E2 ubiquitin conjugating enzyme) recruits and activates the TAK1 (TGFβ- 
activated kinase 1) complex and IKK complex through binding to the regulatory subunits, 
TAB2 and NEMO, respectively (Figure 1.6) (Deng, Wang et al. 2000; Wang, Deng et al. 
2001; Kanayama, Seth et al. 2004; Skaug, Jiang et al. 2009). In the TNFR pathway, 
TRAF2 and TRAF5 (E3s) together with Ubc13 (E2) promote the Lys-63 
polyubiquitination of RIP1 (receptor interacting protein 1) (Tada, Okazaki et al. 2001). The 
polyubiquitinated RIP1 then recruits and activates the TAK1 complex through the 
interaction with TAB2 or TAB3 (Kanayama, Seth et al. 2004). The polyubiquitin chains 
also recruit IKK complex by binding to NEMO, thus allowing TAK1 to phosphorylate and 
activate IKK (Wu, Conze et al. 2006).  
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Figure 1.6 Regulation of NF-κB by Lys63-linked ubiquitination in the IL-1R/Toll-like receptor 
(TLR) pathway. Binding of interleukin-1β (IL-1β) to IL-1R or LPS to TLR4 causes recruitment of 
MyD88, IRAK, and TRAF6 to the receptor. TRAF6, an E3 ubiquitin ligase, catalyzes synthesis of 
Lys63-linked polyubiquitin chains, some of which are conjugated to TRAF6 itself. The 
polyubiquitin chains function as a scaffold to recruit the TAK1 and IKK complexes through 
binding to the regulatory subunits, TAB2 and NEMO, respectively. Recruitment of the kinase 
complexes facilitates autophosphorylation of TAK1 and subsequent phosphorylation of IKKβ by 
TAK1, leading to IκB degradation and subsequent activation of NF-κB (represented by the p50/p65 
dimer). Lys63-linked polyubiquitin chains can be disassembled by deubiquitination enzymes 
including CYLD and A20, which inhibit IKK activation. 
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1.1.5 Inhibition of the NF-κB pathway by deubiquitination 
Polyubiquitination is subject to disassembly by deubiquitination, which is carried out by 
members of deubiquitination enzymes (Dubs) (Amerik and Hochstrasser 2004). Two Dubs 
are best-characterized in inhibiting NF-κB activation to prevent uncontrolled NF-κB 
activities. CYLD (cylindromatosis tumor suppressor protein) inhibits IKK activation by 
cleaving K63-linked polyubiquitin chains on target proteins, including TRAF2, TRAF6 and 
NEMO following stimulation with TNFα or IL-1β (Figure 1.6) (Brummelkamp, Nijman et 
al. 2003; Kovalenko, Chable-Bessia et al. 2003; Trompouki, Hatzivassiliou et al. 2003; 
Skaug, Jiang et al. 2009). Overexpression of CYLD inhibits IKK and NF-κB activation, 
whereas RNAi of CYLD enhances IKK and NF-κB activation.  However, little is known 
about how CYLD activity is regulated in resting cells and during stimulation.  
 A20 is an NF-κB induced Dub protein containing a ovarian tumor (OTU)-type Dub 
domain that inhibits NF-κB in a negative-feedback loop by cleaving K63-linked 
polyubiqutin chains on RIP and TRAF6 following stimulation with TNFα or IL-1β (Boone, 
Turer et al. 2004; Evans, Ovaa et al. 2004; Wertz, O'Rourke et al. 2004; Skaug, Jiang et al. 
2009). Interestingly, A20 contains several zinc-finger domains through which it functions 
as an ubiquitin ligase to assemble K48-linked polyubiquitin chains on RIP after the K63 
chains are cleaved by the OTU domain (Wertz, O'Rourke et al. 2004). K48 
polyubiquitination targets RIP for degradation by the proteasome, further diminishing IKK 
activaton. 
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1.2 NF-κB signalling pathways during pathogen infection 
1.2.1 Pathogen recognition by PRRs 
The innate immune system is the first line of host defense against pathogens and recognizes 
microorganism such as bacteria via germline-encoded pattern recognition receptors (PRRs) 
(Takeuchi and Akira ; Medzhitov 2007). Different PRRs react with specific microbial 
components, known as pathogen-associated molecular patterns (PAMPs). Currently, four 
different classes of PRR families have been identified  (Proell, Riedl et al. 2008). These 
families include transmembrane proteins such as the Toll-like receptors (TLRs) and C-type 
lectin receptors (CLRs), as well as cytoplasmic proteins such as the Retinoic acid-inducible 
gene (RIG)-I-like receptors (RLRs) and NOD-like receptors (NLRs) (see table 1).  
TLRs are evolutionary conserved from Caenorhabditis elegans to mammals (Kawai 
and Akira). To date, 12 members of the TLR family have been identified in mammals. 
TLR2 in combination with TLR1 or TLR6 recognize lipoproteins (triacyl and diacyl 
lipoproteins, respectively), whereas TLR3, TLR7/TLR8, and TLR9 recognize nucleic acids 
(dsRNA, ssRNA and CpG-DNA, respectively). TLR4 and TLR5 recognize 
lipopolysaccharide (LPS) and flagellin, respectively (Akira, Uematsu et al. 2006). 
Recognition of bacterial components by TLRs takes place at either the cell surface or 
endolysosome compartments. 
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Table1. PRRs and their ligands. Adapted from Takeuchi and Akira, 2010 Cell (Takeuchi and Akira). 
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CLRs recognize carbohydrates from viruses, bacteria and fungi via a carbohydrate-
binding domain (Geijtenbeek and Gringhuis 2009). For example, Dectin-1 and Dectin-2 are 
responsible for sensing β-glucans from fungi (Goodridge, Wolf et al. 2009; Robinson, 
Osorio et al. 2009). MINCLE, a CLR from macrophage, can sense not only fungal 
infection but also an endogenous protein, spliceosome-associated protein 130 (SAP130) 
from necrotic host cells (Yamasaki, Ishikawa et al. 2008).  
RLRs are localized in the cytoplasm and primarily sense viral double stranded RNA 
(dsRNA) (Takeuchi and Akira 2009). RLRs are composed of two N-terminal caspase 
recruitment domains (CARDs), a central DEAD box helicase/ATPase domain, and a C-
terminal regulatory domain that mediates the binding to dsRNAs. RIG-1 and MDA5 
recognize relatively short (up to 1kb) and long (more than 2kb) double stranded RNA 
(dsRNA), respectively, and are essential for stimulating type I interferon (IFN) production 
in response to RNA viruses (Kato, Takeuchi et al. 2008; Loo, Fornek et al. 2008). 
NLRs detect pathogens that have invaded the cytosol of host cells. The NLR family 
of proteins is defined by a tripartite structure consisting of a C-terminal leucine-rich repeat 
(LRR) that mediates ligand (pathogen) sensing; a central nucleotide binding 
oligomerization domain (NOD); and a N-terminal effector domain, such as CARDs, 
PYRIN, or baculovirus inhibitor of apoptosis repeat (BIR) domains (Inohara, Chamaillard 
et al. 2005; Martinon and Tschopp 2005) . In human, the NLR family is composed of 22 
proteins (see the Table 2 for the list) (Proell, Riedl et al. 2008). Although primarily 
expressed in immune cells, including antigen-presenting cells such as macrophages and 
dendritic cells, NLRs can also be expressed in nonimmune cells, including epithelial cells 
(Chen, Shaw et al. 2009). Nod1 and Nod2 are the best-characterized NLRs and recognize 
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bacterial peptidoglycan (PGN) fragments D-γ-Glu-meso-diaminopimelic acid (iE-DAP) or 
L-Ala-D-γ-Glu-meso-diaminopimelic acid (Tri-DAP) and muramyl dipeptide (MDP), 
respectively (Figure 1.7) (Chamaillard, Hashimoto et al. 2003; Girardin, Boneca et al. 
2003; Inohara and Nunez 2003).  
Table 2. Overview of NLR family members according to their domain organization (Proell, Riedl et 
al. 2008). 
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Figure 1.7 Nod1 and Nod2 ligands from bacterial peptidoglycan (PGN). Parallel PGN strands 
composed of the alternating amino sugars N-acetylglucosamine (NAG) and N-acetyl muramic acid 
(NAM) are crosslinked to each other by stem peptides. Cross-linking occurs via a direct link 
between a meso-diaminopimelic acid (meso-DAP) residue and the D-alanine residue in position 
four from a peptide anchored on the parallel glycan strand. Minimal motifs required for NOD1 and 
NOD2 (dashed boxes) recognition are also shown. Adapted from Chen et al. (Chen, Shaw et al. 
2009). 
 
1.2.2 NF-κB signal transduction during Shigella infection 
Shigella flexneri (S. flexneri) was the first bacterium shown to be detected by the 
cytoplasmic bacterial sensor NOD1 (Girardin, Tournebize et al. 2001). The Gram-negative 
bacteria Shigella species including S. flexneri, S. dysenteriae, S. boydii, and S. sonnei 
invade the colonic and rectal epithelium of humans, causing an acute mucosal 
inflammation called Shigellosis that leads to the destruction of the colonic mucosa 
(Sansonetti 1998; Schroeder and Hilbi 2008).  
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S. flexneri invades intestinal epithelial cells by inducing cytoskeletal rearrangement 
localized at the site of infection (Bourdet-Sicard, Egile et al. 2000; Tran Van Nhieu, 
Bourdet-Sicard et al. 2000). This entry process depends on the activities of several 
effectors including IpaA, IpaB, IpaC and IpaD secreted from the Shigella type III secretion 
system (T3SS) (High, Mounier et al. 1992; Menard, Prevost et al. 1996; Tran Van Nhieu, 
Ben-Ze'ev et al. 1997; Tran Van Nhieu, Caron et al. 1999). The Shigella effector IpaC 
triggers actin polymerization and the formation of filopodial and lamellipodial extensions, 
which are dependent on the Rho small GTPases Cdc42 and Rac (Mounier, Laurent et al. 
1999), and the protein tyrosine kinase Src (Dehio, Prevost et al. 1995). On the other hand, 
IpaA binds to the focal adhesion protein vinculin and induces depolymerization of actin 
filaments, allowing the transformation of the IpaC-induced extensions into a structure that 
is productive for bacterial entry (Tran Van Nhieu, Ben-Ze'ev et al. 1997).  
Upon entry of Shigella into host cell, a peptidoglycan (PGN)-derived small peptide 
iE-DAP (γ-D-glutamyl-meso-diaminopimelic acid) is released into the cytosol by carboxy-
peptidases and hydrolases activity (Boneca 2005), and sensed by NOD1 (Chamaillard, 
Hashimoto et al. 2003). Recognition of iE-DAP through leucine-rich repeat (LRR) domain 
induces self-oligomerization of NOD1 (Inohara, Koseki et al. 2000). Oligomerization of 
NOD1 allows binding to a downstream effector molecule RICK/RIP2 through CARD-
CARD interaction (Park, Kim et al. 2007). RICK/RIP2 is then conjugated with lysine-63-
linked polyubiquitin chains at lysine 209 (K209) located in its kinase domain by an 
unknown E3 ubiquitin ligase (Hasegawa, Fujimoto et al. 2008). Unlike K48-linked 
polyubiquitin chains, which target a protein for proteasomal degradation, the 
nondegradative K63-linked polyubiquitinated chains further recruit the TAK1 complex via 
  19
CHAPTER 1  GENERAL INTRODUCTION 
TAB2 or TAB3 (Chiu, Zhao et al. 2009). In addition, IKK complex is recruited to 
RICK/RIP2 through the interaction between NEMO and the intermediate domain (IM) of 
RICK/RIP2 (Hasegawa, Fujimoto et al. 2008). Thus, it was suggested that the proximity of 
TAK1 and IKK complex through the interaction with RICK/RIP2 may play an important 
role for NF-κB activation during Nod1 activation (Figure 1.8) (Hasegawa, Fujimoto et al. 
2008). Activation of IKK complex by unknown mechanism leads to the phosphorylation of 
IκBα, which target IκBα for ubiquitination and subsequent degradation by the 26S 
proteasome (Hasegawa, Fujimoto et al. 2008). NF-κB is then free to translocate to the 
nucleus, where it induces expression of a variety of target genes encoding proinflammatory 
cytokines and chemokines, such as interleukin-8 (IL-8) (Chamaillard, Hashimoto et al. 
2003; Arbibe, Kim et al. 2007). The deubiquitinase A20 is also induced by NF-κB, and is 
known to remove K63-linked polyubiquitin chains on RIP and TRAF6 (Boone 2004, Evans 
2004). Thus, it is likely that A20 inhibits NF-κB in a negative-feedback loop by cleaving 
K63-linked polyubiqutin chains on RICK/RIP2 in Nod signaling (Figure 1.8). 
 
 
Figure 8. Model for NF-κB activation in Nod signaling. Adapted from Hasegawa et al.(Hasegawa, 
Fujimoto et al. 2008). 
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1.3 Function and transcriptional regulation of IL-8  
1.3.1 IL-8-mediated inflammatory response to Shigella infection 
When tissues get injured or infected by pathogens like S.flexneri, generally macro 
symptoms of redness, swelling, heat and pain appear. This process is called inflammation 
or inflammatory response. At the cellular level, inflammation is caused by chemical 
mediators called chemokines. Interleukin-8 (IL-8) is one of the major epithelial cells-
secreted chemokines associated with inflammation (Jung, Eckmann et al. 1995). Secreted 
IL-8 then recruits phagocytes, in particular, neutrophils from the blood stream to the site of 
infection (Perdomo, Cavaillon et al. 1994; Kobayashi 2008). The function of IL-8 in 
inflammation during S.flexneri infection was shown in the rabbit model of shigellosis 
where intense IL-8 expression in the infected epithelial layer and neutrophil infiltration in 
the infected tissue was observed (Sansonetti, Tran Van Nhieu et al. 1999). Several recent 
studies have demonstrated that NF-κB activation is required but not sufficient to induce IL-
8 expression upon S.flexneri infection (see below). 
1.3.2 Transcriptional regulation of IL-8 by NF-κB 
IL-8 promoter contains a NF-κB binding site known as kappa B (κB) element that is 
essential for transcriptional regulation of the gene (Mukaida, Mahe et al. 1990; Harant, de 
Martin et al. 1996). In line with the cytoplasmic retention of transcription factor NF-κB by 
its binding to IκB proteins, IL-8 expression is very low in unstimulated cells. Thus, nuclear 
translocation of NF-κB is critical for IL-8 production in response to a wide range of stimuli 
including proinflammatory cytokines such as TNFα, and bacterial products such as LPS or 
PGN (Philpott, Yamaoka et al. 2000). However, binding of the NF-κB element to the IL-8 
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gene promoter is not sufficient. The NF-κB components, especially p65 subunit needs to be 
phosphorylated in its transactivation domain (TD) to be fully active (Hoffmann, Natoli et al. 
2006). Serine 276 phosphorylation in the TD of p65 by protein kinase A (PKA) (Zhong, 
Voll et al. 1998), casein kinase II (CKII) or protein kinase B (PKB or Akt) (Bird, Schooley 
et al. 1997), and serine 536 phosphorylation by IKKα and IKKβ (Sakurai, Chiba et al. 
1999), PI3K/Akt (Sizemore, Leung et al. 1999) and IKKε/TBK1 (Buss, Dorrie et al. 2004; 
Adli and Baldwin 2006) are suggested to be required for its transactivation function.  In 
addition to phosphorylation of NF-κB subunits, acetylation and methylation can modulate 
NF-κB transcriptional activity (Huang, Yang et al. ; Perkins 2006).  
1.3.3 Epigenetic regulation of IL-8 gene  
Epigenetic events such as histone acetylation and phosphorylation are known to play an 
important role in regulating gene expression (Munshi, Shafi et al. 2009). While repression 
of transcriptional activity is commonly correlated with histone hypoacteylation due to 
histone deacetylase (HDAC) activity, histone acetylation mediated by histone 
actetyltransferase (HAT) activity generally promotes transcriptional activation of genes 
after conformational changes within the chromatin (Kuo and Allis 1998; Wilson 2008). 
When it comes to epigenetic regulation of IL-8 gene, Wen et al. have demonstrated that the 
HDAC activity tightly controls the transcription of the IL-8 gene in Caco-2 intestinal 
epithelial cells (Wen and Wu 2001). Muegge et al. have also shown that histone H3 
phosphorylation at serine 10 and acetylation at lysine 14 facilitates NF-κB binding to IL-8 
promoter (Muegge 2002). Histone H3 phosphorylation at serine 10 is induced by mitogen- 
and stress-activated protein kinase 1 (MSK1) downstream of p38 or ERK signaling 
pathways (Thomson, Clayton et al. 1999).  In addition, JNK contributes to IL-8 expression 
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through the activation of the transcriptional regulator AP-1 composed of c-JUN, ATF, c-
FOS, and JDP families, which binds to AP-1-binding site present in the core IL-8 promoter 
(Hess, Angel et al. 2004; Bogoyevitch, Ngoei et al. 2010). 
1.3.4 Subversion of host inflammatory signaling pathways by Shigella effectors 
Subversion of host inflammatory signaling pathways is an important mechanism used by 
multiple bacteria (Bhavsar, Guttman et al. 2007).  Especially, histone modifications 
induced by bacterial toxins are shared by multiple bacteria including S.flexneri, Listeria 
monocytogenes and Helicobacter pylori (see below). For example, the Shigella type III 
effectors OspF (Outer Shigella protein F) induces dephosphorylation of p38 and ERK in 
the nucleus, which subsequently prevents histone H3 Ser10 phosphorylation  (Arbibe, Kim 
et al. 2007; Li, Xu et al. 2007).  L.monocytogenes secretes listeriolysin O (LLO), which 
induces a dramatic dephosphorylation of histone H3 at serine 10 (H3 Ser10) and 
deacetylation of histone H4 (Hamon, Batsche et al. 2007).  Similarly, H. pylori induces 
cagPAI-dependent dephosphorylation of histone H3 at serine 10 and deacetylation of H3 
lysine at lysine 23 (Ding, Fischer et al. 2010).  
Besides OspF, Shigella use other effectors to downregulate the host inflammatory 
response. For example, OspB targets the nucleus to downregulate the host cytokine 
production via interactions with retinoblastoma protein (Rb) (Zurawski, Mumy et al. 2009).  
OspG binds to the ubiquitin-conjugating enzyme UbcH5b and inhibits the degradation of 
IκBα, blocking the NF-κB activation (Kim, Lenzen et al. 2005). IpaH9.8 is an E3 ubiquitin 
ligase that promotes the ubiquitin-binding adaptor protein ABIN-1 (A20 binding inhibitor 
of NF-κB)-dependent polyubiquitination and proteasome-dependent degradation of NEMO, 
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modulating the NF-κB activation and reducing NF-κB-mediated inflammatory response 
(Rohde, Breitkreutz et al. 2007; Ashida, Kim et al. 2010).  
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1.4 NF-κB and diseases 
Given the fact that NF-κB controls hundreds of target genes involved in diverse cellular 
functions, it is not surprising that dysregulation of NF-κB has been implicated in an ever-
expanding list of diseases such as immune deficiency, arthritis, diabetes and cancers (Karin 
and Greten 2005; Okamoto 2006). Epidemiological studies have shown that about 15% of 
human deaths from cancer are associated with chronic viral or bacterial infections (Karin 
and Greten 2005). It is thought that there are 1.2 million cases of infection-related 
maliganancies per year (Kuper, Adami et al. 2000; Bogoyevitch, Ngoei et al. 2010). 
1.4.1 Mutations in NF-κB signaling pathways  
Mutations in NF-κB signaling pathways have been associated with human diseases such as 
chronic inflammatory diseases and immune diseases by affecting expression of target genes 
(Courtois and Gilmore 2006). For example, multiple variants of mutations in Nod2 are 
closely linked to Crohn’s disease, an inflammatory bowel disease, causing inflammation of 
intestine (Hugot, Chamaillard et al. 2001; Bonen, Ogura et al. 2003), whereas certain 
mutations in Nod1 are associated with an increased risk of developing asthma (Hysi, 
Kabesch et al. 2005). A point mutation at serine 32 residue of IκBα is associated with an 
impaired innate immune response and a severe immune deficiency as IκBα 
phosphorylation and degradation (and subsequent NF-κB activation) is impaired in cells 
with this mutation (Courtois, Smahi et al. 2003; Janssen, van Wengen et al. 2004).  
1.4.2 NF-κB as a therapeutic target  
Given the implication in many human diseases, the NF-κB pathway is a good therapeutic 
target. Over 785 inhibitors of the NF-κB pathway have been identified and the number is 
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keep growing (Gilmore 2006). Among those, a number of small chemical compound 
targeting IKK complex are under pre-clinical trials as a therapeutic intervention of cancers 
(Lee and Hung 2008). IKKβ specific inhibitors include PS-1145 (Hideshima, Chauhan et al. 
2002), SPC-839 (Palanki 2002), ML120B (Wen, Nong et al. 2006) and SC-514A (Kishore, 
Sommers et al. 2003).  One of the prominent features of cancer cells is resistance to 
apoptosis via NF-κB dependent anti-apoptotic gene expression. Thus, it is likely that NF-
κB inhibitors can be used to sensitize cancer cells in response to apoptosis-inducing agents. 
A study with sodium salicylate and  asprin known as NF-κB inhibitors has shown that these 
agents decreased NF-κB activation and high levels of the anti-apoptotic protein cFLIP 
expression in leukemic cells, allowing TNFα-induced apoptoiss  (Kopp and Ghosh 1994).  
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1.5 Cellular functions of clathrin 
No function of clathrin in NF-κB signalling pathways has been shown so far, but the 
second part of my thesis reveals a novel clathrin function in NF-κB signalling pathway. 
Thus, it is worth mentioning general information on clathrin in this section.  
1.5.1 Clathrin-mediated endocytosis 
Well-chracterized functions of clathrin include endocytosis of many receptors, channels, 
transporters as well as various soluble macromolecules and viruses (“cargo”) (Conner and 
Schmid 2003). Several motifs for clathrin-dependent internalization are known including 
the tyrosine-based motif (YXXΦ), di-leucine-based motif, NPXY and mono-/multi-
ubiquitination (Mousavi, Malerod et al. 2004). During internalization, adaptor proteins 
recognize trafficking motifs of cargo proteins, link them to clathrin, and concentrate them 
in clathrin-coated pits. The clathrin-coated pits invaginate into the cytoplasm, and 
eventually pinch off from the plasma membrane to form clathrin-coated vesicles in a 
GTPase dynamin-dependent manner (Figure 10) (Conner and Schmid 2003). The main 
component of clathrin-coated pits and vesicles is the clathrin triskelion, consisting of three 
heavy chain (CHC) and three light chain (CLC) (Kirchhausen 2000).  Interactions between 
clathrin and adaptor proteins are mediated through the N-terminal domain of CHC and the 
clathrin boxes (LLpL[-] where L typically denotes a leucine, and p and [-] denote a polar 
and a negatively charged residue, respectively) in adaptor proteins.  For example, AP-2 is a 
heterotetramer composed of α and β2 adaptins and μ2 and σ2 subunits. β2 adaptin contains 
the clathrin box LLNLD. Among others, the transferrin receptor (TfR) is well estabilished 
to be specifically internalized via the clathrin-dependent pathway, and therefore can be 
employed as a marker for clathrin-dependent endocytotic compartments. The μ2 subunit of 
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the AP-2 complex interacts with the internalization motif YXXΦ in the transferrin receptor 
(Owen, Collins et al. 2004). Although the light chain (CLC) is known to be required for 
efficient trimerization and heavy chain stability (Ybe, Greene et al. 1998), it is dispensable 
for the assembly of clathrin with AP complexes (Lindner and Ungewickell 1991) . 
 
 
Figure 10. Clathrin triskelion, AP2 complex and dynamin-dependent endocytosis of transferrin-
transferrin receptor. Clathrin triskelions, composed of three clathrin heavy chains (CHC) and three 
tightly associated light chains (CLC), assemble into a polygonal lattice, which helps to deform the 
overlying plasma membrane into a coated pit. Heterotetrameric AP2 complexes are targeted to the 
plasma membrane by the α-adaptin subunits, where they mediate clathrin assembly through the β2-
subunit, and interact directly with sorting motifs on cargo molecules through their μ2 subunits. 
Dynamin is a multidomain GTPase that is recruited to the necks of coated pits and assemble into a 
  28
CHAPTER 1  GENERAL INTRODUCTION 
spiral, resulting in the scission and release of CCVs. A subsequent uncoating reaction recycles the 
coat constituents for reuse. Adapted from Conner and Schmid 2003. 
 
1.5.2 Endocytosis-independent functions of clathrin  
Many proteins possess multiple and sometimes unexpected functions. This is also the case 
of clathrin, especially its heavy chain (CHC). In addition to the well-characterized function 
in endocytosis, moonlighting functions of CHC in the nucleus have been reported. Ten 
years ago, Okamoto et al. have found that clathrin associates with mitotic spindle during 
mitosis as formation of clathrin-coated vesicles is shut-down in cells undergoing mitosis 
(Okamoto 2006). In 2005, Royle et al. have demonstrated for the first time that clathrin 
stabilizes fibers of the mitotic spindle to assist congression of chromosomes (Royle, Bright 
et al. 2005). They observed that mitosis is prolonged due to destabilized kinetochore fibers 
and defective congression of chromosomes when CHC is depleted by RNAi (Royle, Bright 
et al. 2005). In addition, Enari et al have shown that nuclear CHC binds to the tumor 
suppressor p53 to enhance p53-dependent transactivation, which promotes p53 target gene 
expression (Enari, Ohmori et al. 2006). 
 
1.5.3 Regulation of NF-κB signalling pathway by clathrin-binding proteins of 
endocytic pathway 
Activation of NF-κB is mediated by sequential phosphorylation and activation of signalling 
proteins involved in the NF-κB pathways upon receptor stimulation (e.g.TNFR-RIP-
TAK1-IKK, TLR/IL-1R-IRAK-TAK1-IKK, and Nod1-RIP2-TAK1-IKK). However, how 
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those kinases remain inactive in resting cells is largely unknown. Protein-protein 
interaction studies have revealed that several endocytic proteins play additional function as 
inhibitors of NF-κB signalling pathways. Tom1 (target of Myb1) has been shown to 
interact with Tollip (Toll-interacting protein), forming a complex to regulate endosomal 
trafficking of ubiquitinated proteins such as IL-1R (Brissoni, Agostini et al. 2006). In 
addition, Tollip forms a complex with IRAK (IL-1R-associated kinase) and blocks 
phosphorylation of IRAK, which prevents IKK and NF-κB activation upon stimulation of 
IL-1R but not TNFR (Burns, Clatworthy et al. 2000).  Tom1 is proposed to be a common 
negative regulator of signalling pathways induced by IL-1β and TNFα (Yamakami and 
Yokosawa 2004). Recently, it was shown that Tom1 also inhibits NF-κB activation upon 
TLR2/4 stimulation (Oglesby, Bray et al. 2010). Tom1 can also bind to CHC via a typical 
clathrin binding motif (DLIDMG) and ubiquitin chains (Yamamoto, Verma et al. 2003).  
However, the connection between Tom1/Tollip and CHC in the regulation of NF-κB has 
not been addressed. 
 β-arrestins (β-arrestin 1 and β-arrestin 2) were initially known as negative regulators 
of G-protein-coupled receptors (GPCRs)-mediated signalling (Reiter and Lefkowitz 2006). 
Activation of GPCRs such as β2-adrenergic receptor promotes the recruitment of cytosolic 
β-arrestins to the phosphorylated (activated) receptor. This uncouples the receptor from G 
proteins and promotes the receptor internalization, thus causing desensitization (Claing, 
Laporte et al. 2002). However, new roles of β-arrestins in MAPK signaling, and NF-κB and 
p53-mediated transcriptional regulation have been discovered (Gao, Sun et al. 2004; 
Lefkowitz and Whalen 2004; Shenoy, Drake et al. 2006). β-arrestins-IκBα interaction was 
identified in yeast two-hybrid assays (Witherow, Garrison et al. 2004). Moreover, 
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stimulation of β2-adrenergic receptor in HEK 293, HeLa and COS-7 cells significantly 
increases the amount of β-arrestin 2, which is then associated with IκBα (Gao, Sun et al. 
2004). The interaction with β-arrestin 2 prevents phosphorylation and degradation of IκBα 
and thus attenuates activation of NF-κB and transcription of NF-κB target genes (Gao, Sun 
et al. 2004; Witherow, Garrison et al. 2004). Functional relevance of β-arrestins regulation 
of NF-κB was further confirmed in the NF-κB activating signalling pathways. Luan et al. 
demonstrated that β-arrestin 2 can function as a suppressor of ultraviolet-induced NF-κB 
activation through a direct interaction with IκBα (Luan, Zhang et al. 2005). In addition, 
Wang et al. discovered that β-arrestins modulate TLR/IL-1R-mediated NF-κB signalling 
through their interaction with TRAF6, preventing autoubiquitination of TRAF6 (Wang, 
Tang et al. 2006). However, different from the β-arrestins- IκBα interaction, stimulation of 
β2-adrenergic receptor has no effect on the interaction of β-arrestins and TRAF6, 
suggesting that β-arrestins-TRAF6 interaction is regulated by IL1R independently of 
GPCR stimulation (Wang, Tang et al. 2006). β-arrestins can bind to clathrin through the C-
terminal clathin binding domain (Krupnick, Goodman et al. 1997). 
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1.6 Aim of the study  
 
Nuclear factor-kappaB (NF-κB) is a cytosolic transcription factor in resting cells and 
translocates into the nucleus and becomes active in response to pro-inflammatory stimuli 
and bacterial infection. The IKK complex contains two catalytic subunits IKKα and IKKβ 
and is essential for the activation of NF-κB through phosphorylation and degradation of the 
inhibitor of NF-κB (IκBα). IKKα and IKKβ are structurally similar but functionally distinct 
each other, with IKKα being important for lymphocyte organogenesis but IKKβ being 
critical for inflammation and innate immunity.   
The primary goal of my Ph.D. thesis research was to identify signaling proteins 
important for NF-κB regulation in resting cells and in response to Shigella flexneri. Initial 
efforts have been focused on an RNAi screen. Following the screen, special aims of the 
follow-up studies were: 
 
1) To reveal an unknown function of IKKα in inflammation and innate immunity  
 
2) To investigate an endocytosis-independent function of clathrin heavy chain 
(CHC) in the regulation of basal NF-κB activation.  
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CHAPTER 2   IKKα regulation of canonical NF-κB activation 
2.1 ABSTRACT 
Background: During pathogen infection, innate immunity is initiated via the recognition of 
microbial products by pattern recognition receptors and the subsequent activation of 
transcription factors that upregulate proinflammatory genes. By controlling the expression 
of cytokines, chemokines, anti-bacterial peptides and adhesion molecules, the transcription 
factor nuclear factor-kappa B (NF-κB) has a central function in this process. In a typical 
model of NF-κB activation, the recognition of pathogen associated molecules triggers the 
canonical NF-κB pathway that depends on the phosphorylation of Inhibitor of NF-κB (IκB) 
by the catalytic subunit IκB kinase β (IKKβ), its degradation and the nuclear translocation 
of NF-κB dimers.  
Methodology: Here, we performed an RNA interference (RNAi) screen on Shigella 
flexneri-induced NF-κB activation to identify new factors involved in the regulation of NF-
κB following infection of epithelial cells by invasive bacteria. By targeting a subset of the 
human signaling proteome, we found that the catalytic subunit IKKα is also required for 
complete NF-κB activation during infection. Depletion of IKKα by RNAi strongly reduces 
the nuclear translocation of NF-κB p65 during S. flexneri infection as well as the 
expression of the proinflammatory chemokine interleukin-8. Similar to IKKβ, IKKα 
contributes to the phosphorylation of IκBα on serines 32 and 36, and to its degradation. 
Experiments performed with the synthetic Nod1 ligand L-Ala-D-γ-Glu-meso-
diaminopimelic acid confirmed that IKKα is involved in NF-κB activation triggered 
downstream of Nod1-mediated peptidoglycan recognition. 
Conclusions: Taken together, these results demonstrate the unexpected role of IKKα in the 
canonical NF-κB pathway triggered by peptidoglycan recognition during bacterial infection. 
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In addition, they suggest that IKKα may be an important drug target for the development of 
treatments that aim at limiting inflammation in bacterial infection.  
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2.2 INTRODUCTION 
During pathogen infection, structurally conserved microbial molecules are recognized by 
germline-encoded pathogen recognition receptors (PRRs) that function as sensors for non-
self detection and initiate innate immunity (Takeuchi and Akira ; Medzhitov 2007). PRRs 
include transmembrane proteins such as Toll-like receptors and C-type lectin receptors, as 
well as cytoplasmic proteins such as retinoic acid-inducible gene (RIG)-I-like receptors and 
NOD-like receptors (Blasius and Beutler ; Franchi, Park et al. 2008; Kawai and Akira 
2008). They are expressed in macrophages and dendritic cells but also in various non-
professional immune cells including epithelial and endothelial cells. PRRs recognize a 
large variety of pathogen associated molecular patterns (PAMPs) from both extracellular 
and intracellular pathogens including lipopolysaccharide, peptidoglycan, lipoproteins, 
dsRNA, ssRNA, CpG-DNA and flagellin (Rasmussen, Reinert et al. 2009). Signaling 
pathways of PAMP recognition converge into the activation of the pleiotropic transcription 
factor nuclear factor-kappa B (NF-κB) that, in the context of innate immunity, regulates the 
expression of proinflammatory genes encoding cytokines, chemokines, anti-bacterial 
peptides and adhesion molecules (Beutler 2009). The mammalian NF-κB family consists of 
the members RelA/p65, RelB, c-Rel, p50 (NF-κB1) and p52 (NF-κB2) (Hayden and Ghosh 
2004). All five proteins share a Rel homology domain and form homo- and heterodimers 
that regulate transcription by binding to κB sites in promoters or enhancers of target genes. 
In unstimulated cells, most of the NF-κB dimers are sequestrated in the cytoplasm by the 
proteins of the Inhibitor of NF-κB (IκB) family whose prototype is IκBα. In the canonical 
pathway of NF-κB activation triggered by most stimuli including bacterial and viral 
infection, cytokines and stress-induced responses, phosphorylation of IκBα on Serine 32 
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and Serine 36 residues by the IκB kinase (IKK) complex is a decisive regulatory step (Solt 
and May 2008). The IKK complex is comprised of three subunits: two catalytic subunits, 
IKKα and IKKβ, and the regulatory scaffold component NF-κB essential modulator 
(NEMO). The respective contribution of IKKα and IKKβ in the phosphorylation of IκBα is 
unclear. Although it is generally accepted that IKKβ is critical for IκBα phosphorylation 
through the canonical pathway, two recent reports demonstrate the equal importance of 
IKKα for the activation of NF-κB by the inflammatory cytokines interleukin-1 (IL-1) in 
mouse embryonic fibroblasts and tumor necrosis factor alpha (TNFα) in HeLa cells (Adli, 
Merkhofer et al. ; Solt, Madge et al. 2007). The phosphorylation of IκBα is followed by its 
rapid polyubiquitination and subsequent degradation by the 26S proteasome complex 
(Gilmore 2006). The release of NF-κB with unmasked nuclear localization sequence leads 
then to the translocation of the transcription factor to the nucleus where it regulates gene 
expression (Hayden and Ghosh 2008).  
 Although the role of NF-κB is central to many pathways triggered by 
pathogen recognition, the molecular processes that govern its activation are only partially 
elucidated. In particular, the mechanisms triggered by the detection of invasive bacteria 
such as the pathogen Shigella flexneri remain largely uncharacterized. S. flexneri makes use 
of a type III secretion (T3S) apparatus to locally rearrange the host actin cytoskeleton and 
penetrate into intestinal epithelial cells (Schroeder and Hilbi 2008). Once internalized, 
bacteria multiply in the host cytoplasm and use actin-based motility to spread to adjacent 
epithelial cells. During infection, massive inflammation is observed in colonic mucosal 
tissues (Islam, Veress et al. 1997). In infected epithelial cells, intracellular bacteria release 
peptidoglycan-derived peptides that are specifically recognized by Nod1 (Girardin, Boneca 
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et al. 2003). Upon ligand binding, Nod1 homo-dimerizes and recruits the downstream 
kinase RICK/RIPK2 through heterologous caspase-recruitment domain interactions 
(Inohara, Koseki et al. 2000). This converges to the sequential recruitment and activation of 
the TAK1/TAB1/TAB2 and IKKα/IKKβ/IKKγ complexes, the nuclear translocation of NF-
κB and the upregulation of proinflammatory genes encoding for cytokines and chemokines, 
including interleukin-8 (IL-8) and TNFα (Sansonetti, Arondel et al. 1999). The chemokine 
IL-8 recruits polymorphonuclear cells to the site of infection and therefore contributes to 
contain the dissemination of bacteria within the intestinal tissue. Interestingly, S. flexneri 
uses the T3S apparatus to secrete several effectors that alter multiple signaling pathways in 
infected cells and reduce the expression of proinflammatory genes (Ogawa, Handa et al. 
2008). Among others, the effector OspF suppresses the expression of IL-8 by 
dephosphorylating the MAP kinases p38 and ERK in the nucleus of infected cells (Arbibe, 
Kim et al. 2007; Li, Xu et al. 2007), thereby impairing the phosphorylation of Histone H3, 
a process that regulates the access of chromatin to transcription factors.  
 Here, we performed an RNA interference (RNAi) screen on S. flexneri-
induced NF-κB activation to identify new factors involved in the regulation of NF-κB 
following infection of epithelial cells by invasive bacteria. By targeting a subset of the 
human signaling proteome, we identified IKKα as a protein required for S. flexneri-induced 
NF-κB nuclear translocation and IL-8 secretion in HeLa cells. This result was unexpected 
because, except for IL-1 and TNFα (Adli, Merkhofer et al. ; Solt, Madge et al. 2007), it is 
generally accepted that IKKβ is the component of the IKK complex involved in the 
canonical pathway of NF-κB activation. Depletion of IKKα or IKKβ indicated that S. 
flexneri-induced NF-κB activation in HeLa cells requires indeed both catalytic subunits. 
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We further characterized the role of IKKα and found that, during S. flexneri infection, 
IKKα was required for the phosphorylation of IκBα on serines 32 and 36, and for its 
degradation. Experiments performed with the synthetic Nod1 ligand L-Ala-D-γ-Glu-meso-
diaminopimelic acid (Tri-DAP) indicated that IKKα was involved in Nod1-mediated 
signaling pathway of NF-κB activation. Taken together, these results show that, although 
Nod1 signaling triggers the canonical pathway of NF-κB activation, both IKKα and IKKβ 
are required for full NF-κB activation.  
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2.3 MATERIALS AND METHODS 
 
Antibodies and reagents 
Antibodies against NF-κB p65, IκBα and IKKα were obtained from Santa Cruz 
Biotechnology (Santa Cruz, USA) whereas the anti-actin was from Chemicon (Billerica, 
USA) and the anti-phospho-IκBα was from Cell signaling technology (Beverly, USA). The 
anti-mouse IgG-Cy5 was obtained from Zymed (San Francisco, USA) and the anti-rabbit 
IgG-HRP and anti-mouse IgG-HRP from GE Healthcare (Pittsburgh, USA). Hoechst and 
FITC-phalloidin were from Invitrogen (Carlsbad, USA), TNFα from R & D systems 
(Minneapolis, USA).  
 
Cell culture and transfection 
HeLa cells were maintained in Dulbecco’s modified Eagle’s medium (high glucose) 
supplemented with 10% fetal bovine serum, 100 units/ml penicillin, and 100 μg/ml 
streptomycin at 37 °C in 10% CO2. HeLa cells were transfected with siRNAs and DNA 
plasmids using Lipofectamine 2000 (Invitrogen, Carlsbad, USA) and jetPEI (Poly plus 
transfection, Illkirch, France), respectively. siRNAs ON-TARGETplus SMARTpool 
targeting IKKα (#L-003473-00-005) and ON-TARGETplus siCONTROL (Dharmacon, 
Dallas, USA) were used in all our study except for the experiments where IKKα, IKKβ and 
NEMO were silenced in parallel. In this case, all siRNAs were from Qiagen (Valencia, CA, 
USA).  
 
In vitro diced siRNA library 
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 An in vitro diced siRNA library targeting 132 genes coding for a subset of the signaling 
proteome was generated as previously described (Liou, Kim et al. 2005; Brandman, Liou et 
al. 2007; Galvez, Teruel et al. 2007). Briefly, for each gene, a 600 base pair cDNA was 
generated by PCR from a total cDNA library. An additional set of nested primers was used 
to add T7 promoters at both ends of the final cDNA fragment. Nested PCR products were 
subject to in vitro transcription, dicing, and purification to produce gene specific siRNA 
pools. Dicing was performed with the turbo dicer siRNA generation kit from Genlantis 
(San Diego, USA). The concentration of all siRNA pools was normalized.  
 
Bacterial strains  
The S. flexneri strains M90T wild-type and the icsA (virG) deletion mutant (ΔvirG) were 
generously provided by Dr. P. Sansonetti (Institut Pasteur, Paris, France). All strains were 
transformed with the pMW211 plasmid to express the DsRed protein under control of a 
constitutive promoter. The pMW211 plasmid was a generous gift from Dr. D. Bumann 
(Biozentrum, University of Basel, Switzerland). The ΔospF deletion mutant used in IL-8 
expression experiments, was generated from the ΔvirG mutant by allelic exchange using a 
modification of the lambda red-mediated gene deletion (Datsenko and Wanner 2000). 
Briefly, the genes for lambda red recombination were expressed from the pKM208 plasmid 
(Murphy and Campellone 2003). The chloramphenicol resistance cassette (cat) of the 
pKD3 plasmid was amplified using the primers listed in Table 1. After DpnI digestion, the 
PCR product was electroporated into the ΔvirG mutant. Recombinants were selected on 
TSB plates containing 5 or 10 μg ml-1 chloramphenicol. The cat cassette was removed by 
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-1transformation of pCP20 and incubation at 30°C on TSB plates containing 100 μg ml  
ampicillin (Datsenko and Wanner 2000). Single colonies were screened by PCR.  
 
Table 1. Oligonucleotide primers used to generate the ΔospF mutant. 
Mutant Forward Reverse 
ATTCTATTATATAGATAAAATATCT
CCTGCAAAAGATACGGGTATTTT 
TCAAAAGTTCGATGTTCCACCACAT
CGACCGTAGAAGAGATGAGATAGTA∆ospF 
TGTGTAGGCTGGAGCTGCTTCG CATATGAATATCCTCCTTAG
 
 
Infection assay 
Bacteria were routinely grown in tryptic soy broth (TSB) medium, used in exponential 
growth phase, and treated with poly-L-lysine prior infection. HeLa cells, seeded in 96-well 
plates, were serum starved for 30 min and infected with S. flexneri at a multiplicity of 
infection (MOI) of 10. Immediately after adding bacteria, the plates were centrifuged for 5 
min at 2000 rpm and placed at 37°C for 30 min. Extracellular bacteria were killed by 
addition of gentamycin (50 μg/ml).  
 
Immunofluorescence  
Cells were fixed with 4% PFA for 6 min and permeabilized in 0.5% Triton X-100 for 10 
min. They were, then, incubated with a mouse monoclonal anti-p65 antibody (1 μg/ml) 
overnight at 4 °C and stained with a Cy5-conjugated secondary antibody and Hoechst (10 
μg/ml) for 40 min at room temperature.  
 
siRNA screen of S. flexneri-induced p65 nuclear translocation 
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The in vitro diced siRNA library was screened on S. flexneri-induced p65 translocation 
assay in a 96-well format. The firefly luciferase (GL3) siRNA was used as a non-silencing 
negative control as described previously (Liou, Kim et al. 2005; Brandman, Liou et al. 
2007; Galvez, Teruel et al. 2007). siRNA pools against Nod1, RIPK2 and Src were used as 
positive controls. The screen was performed three times in duplicate as follows. Three 
thousand HeLa cells per well were transfected by reverse transfection with the individual 
132 siRNA pools in 96-well plates. After 48 hours, cells were infected with DsRed S. 
flexneri at MOI of 10 for 90 min and then fixed, permeabilized, and stained for p65, F-
actin, and DNA. Images were acquired at 12 random sites of each well using the automated 
ImageXpress microscope (Molecular devices, Sunnyvale, USA). At each site, images at 
360 nm, 480 nm, 594 nm, 640 nm were acquired to visualize Hoechst, Phalloidin, DsRed S. 
flexneri and p65, respectively. The nuclear localization of p65 was automatically quantified 
by using the Enhanced-Translocation module of MetaXpress (Molecular devices, 
Sunnyvale, USA). Briefly, the Hoechst staining was used as a mask to automatically 
identify nuclei in the p65 staining image. The cytoplasmic area was defined by a ring 
around each nucleus. For each cell, the ratio of p65 intensity in the nucleus and in the 
cytoplasmic ring defined as the Nuc/Cyt p65 ratio was calculated and averaged over 
several thousands of cells per well. The results of the screen were expressed as individual 
scores. The score of a particular gene represents the fold standard deviation from the mean 
of the GL3 control wells. A negative or a positive sign was assigned to the score when the 
Nuc/Cyt p65 ratio was lower or higher than the GL3 control ratio, respectively.  
 
Enzyme- linked Immunosorbent Assay (ELISA) 
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IL-8 secretion was measured by ELISA in the supernatant of HeLa cells 6 hours post 
infection. Cell-free supernatants from triplicate wells were analyzed for their IL-8 content 
using a commercial ELISA kit (BD Pharmingen, San Jose, USA).  
 
Western Blot Analysis 
HeLa cells were transfected with siRNAs in a 6-well plate. 72 hours post transfection, cells 
were lysed in Phosphosafe Extraction Buffer (Novagen, Darmstadt, Germany) 
supplemented with 1x protease inhibitor cocktail (Calbiochem, Darmstadt, Germany). 
Protein concentration was measured using the bicinchonic acid (BCA) kit (Pierce, 
Rockford, USA). Equal amounts of proteins were resolved by SDS-PAGE and transferred 
to Hybond C-Extra membrane (Amersham Bioscience, Pittsburgh, USA) for 
immunoblotting with individual antibodies. Primary antibodies were detected using 
horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG antibodies, and visualized 
with the ECL system (Pierce). Quantification of the blots was performed using the 
densitometry feature of Photoshop.  
 
Tri-DAP treatment 
Cells were serum starved 30 min before treatment with L-Ala-γ-D-Glu-mesoDAP (Tri-
DAP). Tri-DAP treatment was performed by calcium phosphate transfection using 0.4 
μg/ml Tri-DAP final concentration for 90 min. Then cells were fixed with 4% PFA and 
analyzed by immunofluorescence as described above.  
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Statistical analysis 
Data are expressed as mean ± standard deviation calculated from the number of replicates 
specified in figure legends. p values were calculated with a two-tailed two-sample equal 
variance t-test. 
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2.4 RESULTS 
2.4.1 RNAi screen identifies the role of IKKα in the nuclear translocation of NF-κB 
p65 during infection of epithelial cells by S. flexneri 
Over the past 10 years, RNAi has been an essential tool to study gene function in 
mammalian cells (Liou, Kim et al. 2005; Pelkmans, Fava et al. 2005; Zhang, Liu et al. 
2009). Using S. flexneri-induced NF-κB activation in HeLa cells as a model system, we 
performed an image-based RNAi screen to identify new proteins involved in the molecular 
mechanisms that control NF-κB activation following pathogen recognition. The nuclear 
localization of NF-κB p65 visualized by anti-p65 immunofluorescence microscopy was 
used as readout for NF-κB activation. In uninfected cells, p65 was mainly localized in the 
cytoplasm (Figure 2.1A, left panel). In contrast, following infection with dsRed-expressing 
S. flexneri, a strong nuclear translocation of p65 was observed (Figure 2.1A, right panel). 
To validate the RNAi approach, silencing of the intracellular pattern recognition receptor 
Nod1 involved in S. flexneri recognition was tested. HeLa cells were transfected with pools 
of in vitro diced small interference RNA (siRNA) targeting Nod1 or the firefly Luciferase 
used as control (GL3). After 48 hours, cells were infected with S. flexneri, stained for p65 
and DNA with an anti-p65 antibody and Hoechst, respectively. Visual inspection of images 
showed that S. flexneri-induced p65 nuclear translocation was suppressed in Nod1-depleted 
cells (Figure 2.1B). This observation was quantified by measuring for each cell the ratio of 
p65 intensity in the nucleus and in the cytoplasm by automated image processing (Figure 
2.1C). The Hoechst staining was used to automatically identify nuclei whereas the 
cytoplasmic area was defined by a ring around each nucleus. Quantification of the 
Nucleus/Cytoplasm p65 intensity ratio (Nuc/Cyt p65 ratio) confirmed that the depletion of 
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Nod1 inhibited the nuclear translocation of p65 induced during infection (Figure 2.1D), and 
therefore, that the RNAi approach was suitable to identify new proteins involved in the 
activation of NF-κB during S. flexneri infection of epithelial cells.  
An in vitro diced siRNA library targeting 132 genes from the human signaling 
proteome was screened on S. flexneri-induced p65 nuclear translocation as described in 
Materials and Methods. For each gene, a score representing the fold standard deviation 
from the mean of GL3 control wells was calculated (Figures 2.1E and Table S1). A 
negative or a positive sign was attributed to the score when the Nuc/Cyt p65 ratio was 
lower or higher than the GL3 ratio, respectively. As expected, Nod1 and RIPK2, two key 
proteins involved in S. flexneri-induced NF-κB activation (Girardin, Tournebize et al. 
2001; Girardin, Boneca et al. 2003), as well as Src, a tyrosine kinase required for bacterial 
entry into cells (Dehio, Prevost et al. 1995), obtained strong negative scores (Figures 2.1E 
and Table S1). Using an arbitrarily determined cut off score value of +/- 3.5, the proteins 
CHUK/IKKα, FGD3, Arf1, GIT1, Rab23, ARHN, RabGGTA, HIPK2 and CLTC were 
classified as hits (Figures 2.1E and Table S1). The identification of IKKα, also known as 
CHUK, was unexpected as peptidoglycan recognition via Nod1 triggers the canonical NF-
κB pathway, and was, therefore, thought to be exclusively dependent on IKKβ and 
NEMO. The contribution of IKKα in the mechanisms that control NF-κB activation 
following S. flexneri infection was then further explored.  
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Figure 2.1. RNAi screen identifies the role of IKKα in p65 nuclear translocation during S. 
flexneri infection  
(A) NF-κB p65 translocates to the nucleus in response to S. flexneri infection. HeLa cells were left 
untreated (Mock) or infected with dsRed-expressing S. flexneri for 60 minutes at MOI=10. NF-κB 
p65 localization was visualized by immunofluorescence microscopy. An overlay image is shown 
for S. flexneri (green) and p65 (red). (B) Depletion of Nod1 by RNAi inhibits the nuclear 
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translocation of NF-κB p65 in response to S. flexneri infection. HeLa cells were transfected with 
GL3 or Nod1 siRNA and infected with S. flexneri for 60 minutes at MOI=10. p65 and DNA were 
visualized by anti-p65 and Hoechst staining, respectively. (C) Images illustrating the quantification 
of the p65 ratio. The Hoechst staining was used as a mask to automatically identify the nuclei in the 
p65 staining image. The cytoplasmic area was defined by a ring surrounding each nucleus. Scale 
bars, 10 μm (D) Quantification of the p65 ratio in control and Nod1-depleted cells following 
infection by S. flexneri. Results represent the mean ± SD of 12 images; graph representative of 3 
independent experiments. (E) RNAi screen of S. flexneri-induced p65 nuclear translocation in HeLa 
cells. Scores are fold standard deviations from the mean of GL3 control wells. Dashed lines 
represent scores of ± 3.5 (See Materials and Methods for details).  
 
 
2.4.2 Depletion of IKKα   inhibits S. flexneri-induced p65 nuclear translocation and 
IL-8 expression without affecting bacterial invasion 
First, to validate the role of IKKα in S. flexneri-induced p65 nuclear translocation, we 
tested a pool of four synthetic IKKα siRNAs that had no overlapping sequences with the in 
vitro diced siRNAs used in the screen. In conditions where around 90% of endogenous 
protein was depleted (Figure 2.2A), a massive reduction of p65 nuclear translocation was 
observed (Figures 2.2B and 2.2C). This result was not explained by a reduction of bacterial 
uptake as the number of internalized bacteria was similar in control and in IKKα-depleted 
cells (Figure 2.2B). Taken together, these results indicated that IKKα is required for the 
activation of NF-κB during infection of epithelial cells by S. flexneri.  
During infection, NF-κB positively regulates the expression of multiple 
proinflammatory genes (Pedron, Thibault et al. 2003). In particular, it induces the 
expression of the chemokine IL-8, which recruits PMNs on site of infection, and thereby 
limits the spread of bacterial invasion within the intestinal tissue (Sansonetti, Arondel et al. 
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1999). To test whether IKKα contributed to the upregulation of IL-8 expression during 
infection, we measured by ELISA the secretion of IL-8 in the supernatant of control and 
IKKα-depleted HeLa cells six hours post infection. To increase the amount of IL-8 
produced in response to infection, cells were infected with a mutant of S. flexneri deleted 
for the type III effector OspF (ΔospF) that dampens inflammation signaling by 
dephosphorylating p38 in the nucleus of infected cells (Arbibe, Kim et al. 2007). 
Consistent with NF-κB data, a reduction of IL-8 secretion was observed in response to S. 
flexneri ΔospF infection when cells were depleted for IKKα  (Figure 2.2D), showing that 
IKKα is involved in the signaling pathways that control the expression of a critical 
inflammatory chemokine during bacterial infection.  
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Figure 2.2. Depletion of IKKα  inhibits S. flexneri-induced p65 nuclear translocation and IL-8 
expression without affecting bacterial invasion 
(A) IKKα expression is effectively reduced by RNAi. HeLa cells were transfected with the 
indicated siRNAs. Western blots were performed on cell lysates. Actin levels are shown as a 
loading control. (B) Depletion of IKKα  inhibits S. flexneri-induced p65 nuclear translocation and 
IL-8 expression without affecting bacterial invasion. HeLa cells were transfected with control or 
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IKKα siRNA and infected with S. flexneri for 60 minutes at MOI=10. An overlay is shown for S. 
flexneri (green) and p65 (red), right panel. (C) Time course of p65 nuclear translocation during S. 
flexneri infection of control and IKKα-depleted cells. Results represent the mean ± SD of 12 
images; graph representative of 2 independent experiments. (D) S. flexneri-induced IL-8 secretion 
is impaired by the depletion of IKKα. IL-8 secretion was measured by ELISA in the supernatant of 
control or IKKα-depleted HeLa cells left untreated (Mock) or infected with S. flexneri ΔospF. 
Results represent the mean ± SD of 6 wells; graph representative of 3 independent experiments, 
*p=0.006. 
 
 
2.4.3 Both IKKα and IKKβ contribute to the phosphorylation and the degradation of 
IκBα during S. flexneri infection  
It is generally believed that IKKβ and NEMO are the two subunits of the IKK 
complex involved in the canonical pathway of NF-κB activation. To test the contribution of 
all IKK subunits in the activation of NF-κB during infection of epithelial cells by S. 
flexneri, we monitored the localization of p65 in cells depleted for IKKα, IKKβ or NEMO. 
As shown in Figure 2.3A, the depletion of either of these proteins reduced the nuclear 
translocation of p65, indicating that both catalytic subunits IKKα and IKKβ, as well as the 
scaffolding function of NEMO were required to fully activate the NF-κB pathway during 
infection. IKKβ regulates the canonical pathway of NF-κB activation by phosphorylating 
IκBα at positions serine 32 and 36, thereby inducing its polyubiquitination and subsequent 
degradation (Solt and May 2008). To test whether IKKα regulated NF-κB via a similar 
mechanism, we monitored the phosphorylation of IκBα at serines 32 and 36 (pIκBα) and its 
degradation following infection of HeLa cells by S. flexneri. Whereas massive 
phosphorylation and degradation of IκBα were observed in control cells following 
infection, these two processes were strongly reduced after IKKα knockdown (Figure 2.3B), 
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indicating that IKKα largely contributes to the phosphorylation and degradation of IκBα 
during infection by S. flexneri.  
 
Figure 2.3. Both IKKα and IKKβ catalytic subunits contribute to NF-κB activation during 
infection by S. flexneri. 
(A) Depletion of IKKα, IKKβ or NEMO reduces the translocation of p65 during S. flexneri. S. 
flexneri-induced p65 translocation was analyzed in HeLa cells transfected with control, IKKα, 
IKKβ and NEMO siRNAs. Results represent the mean ± SD of 12 images; graph representative of 
2 independent experiments. (B) IKKα is involved in the phosphorylation and the degradation of 
IκBα during S. flexneri infection. Control or IKKα-depleted HeLa cells were left untreated or 
infected with S. flexneri for the indicated periods at MOI=10. Levels of IKKα, pIκBα and IκBα 
were monitored by western blots performed on cell lysates. Actin levels are shown as a loading 
control.  
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2.4.4 IKKα is involved in Nod1-mediated peptidoglycan recognition  
During S. flexneri infection, the activation of NF-κB is initiated by the recognition of 
peptidoglycan fragments via the intracellular receptor Nod1 (Girardin, Boneca et al. 2003). 
To specifically examine the implication of IKKα in Nod1-mediated signaling, the effect of 
IKKα depletion was directly tested in cells exposed to the Nod1 ligand Tri-DAP. Whereas 
Tri-DAP treatment induced a clear nuclear translocation of p65 in control cells, this 
translocation was severely impaired in IKKα-depleted cells (Figures 2.4A and 2.4B), 
demonstrating that IKKα is required for the activation of NF-κB following Nod1-mediated 
peptidoglycan recognition.  
 
 
Figure 2.4 IKKα is required for the activation of NF-κB induced by Nod1-mediated 
peptidoglycan recognition 
(A) IKKα depletion reduces the activation of NF-κB induced by Nod1-mediated peptidoglycan 
recognition. Control or IKKα-depleted HeLa cells were treated with Tri-DAP as described in 
Materials and Methods. After 1 hour, cells were fixed, stained for p65 and DNA with an anti-p65 
antibody and Hoechst, respectively. (B) Quantification of the effect of IKKα depletion on Tri-DAP-
induced p65 nuclear translocation. Results represent the mean ± SD of 12 images; graph 
representative of 3 independent experiments, **p ≤ 8.6E-4, ns: non-significant.  
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2.5 DISCUSSION 
Although NF-κB is a transcription factor that has been the subject of intensive 
research by academic laboratories and the pharmaceutical industry, the complex molecular 
mechanisms controlling its activation are only partially elucidated. Here we performed an 
RNAi screen to identify new proteins involved in the mechanisms that control NF-κB 
activation following pathogen recognition using infection of epithelial cells by the invasive 
bacterium S. flexneri as a model system. The presence of S. flexneri in the cytoplasm is 
recognized via the detection of peptidoglycan by the receptor Nod1 (Girardin, Boneca et al. 
2003). This recognition leads to NF-κB activation and the upregulation of proinflammatory 
genes that orchestrate the host inflammatory response (Pedron, Thibault et al. 2003). The 
protein IKKα was identified in the screen as a protein required for the activation of NF-κB 
in response to S. flexneri infection. Since bacterial uptake was not affected by the depletion 
of IKKα, this result indicated that IKKα is involved in the activation of NF-κB in response 
to infection. The depletion of IKKβ or NEMO also induced a reduction of S. flexneri-
induced-p65 nuclear translocation, confirming that all subunits were required for the full 
activation of NF-κB during infection. As the translocation of p65 depends on the 
degradation of IκBα primed by its phosphorylation on serines 32 and 36, the role of IKKα 
in these two processes was analyzed. A reduction of IκBα phosphorylation and delayed 
degradation were observed in cells depleted for IKKα ,  indicating that similar to IKKβ, 
IKKα triggers NF-κB activation by inducing the phosphorylation and the degradation of 
IκBα. Taken together, these results provided new evidence for a role of IKKα in the 
canonical pathway of NF-κB activation, and were in line with few reports indicating that 
the dominant model of canonical NF-κB activation based on IKKβ and NEMO is 
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incomplete. In particular, it has been reported that IKKα is the key subunit responsible for 
the Receptor activator of NF-κB (RANK)-induced classical NF-κB activation in mammary 
epithelial cells (Cao, Bonizzi et al. 2001). In addition, Solt et al. showed that IL-1-induced 
NF-κB activation requires the interaction of IKKα with NEMO and occurs in the absence 
of IKKβ (Solt, Madge et al. 2007) . Finally, it has been shown recently that both IKKα and 
IKKβ contribute to IκBα phosphorylation and NF-κB activation in response to TNFα 
stimulation in HeLa cells (Adli, Merkhofer et al.). For the first time, our results 
demonstrate that IKKα is also implicated in the canonical pathway of NF-κB activation 
triggered by bacterial infection. To further demonstrate that pathogen recognition induced 
NF-κB activation in an IKKα-dependent manner during S. flexneri infection, we directly 
tested whether IKKα was involved in the activation of NF-κB induced by Nod1-mediated 
peptidoglycan recognition. For this purpose, controls or IKKα-depleted cells were directly 
stimulated with the purified Nod1 ligand Tri-DAP. The analysis of the p65 nuclear 
translocation showed that IKKα was required for the full activation of NF-κB in response 
to Tri-DAP treatment, indicating that IKKα is involved in the molecular mechanism 
signaling the recognition of peptidoglycan-derived peptides by Nod1. 
Following infection of epithelial cells by S. flexneri, the activation of NF-κB leads 
to the upregulation of genes encoding for inflammatory cytokines including IL-8 and TNFα 
(Pedron, Thibault et al. 2003). To confirm the implication of IKKα in the expression of 
genes induced by the canonical NF-κB pathway, the deletion of IKKα was tested on S. 
flexneri-induced IL-8 expression. Consistent with NF-κB data, the secretion of IL-8 was 
reduced when IKKα was depleted, showing that the contribution of IKKα to NF-κB 
activation has a functional impact on the amplitude of the inflammatory response mounted 
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in response to bacterial infection. These results suggest that inhibition of IKKα activity 
may be critical to control inflammation upon bacterial infection. Inhibitors of IKKβ have 
demonstrated therapeutic benefits in various animal models of inflammatory diseases and 
are currently in early clinical trials (Ogawa, Azuma et al. ; Ziegelbauer, Gantner et al. 
2005; Izmailova, Paz et al. 2007). The data presented in this manuscript suggest that IKKα 
inhibitors should also be developed and used in combination with IKKβ inhibitors to limit 
inflammation during bacterial infection or in inflammatory disorders that may involve 
Nod1 signaling, including asthma, eczema and inflammatory bowel diseases (Reijmerink, 
Bottema et al. ; Weidinger, Klopp et al. 2005; Le Bourhis, Benko et al. 2007).  
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3.1 ABSTRACT 
 
Background: Nuclear factor-κB (NF-κB) is a transcription factor that regulates the 
transcription of genes involved in a variety of biological processes, including innate and 
adaptive immunity, stress responses and cell proliferation. Constitutive or excessive NF-κB 
activity has been associated with inflammatory disorders and higher risk of cancer. In 
contrast to the mechanisms controlling inducible activation, the regulation of basal NF-κB 
activation is not well understood. Here we test whether clathrin heavy chain (CHC) 
contributes to the regulation of basal NF-κB activity in epithelial cells.  
 
Methodology: Using RNA interference to reduce endogenous CHC expression, we found 
that CHC is required to prevent constitutive activation of NF-κB and gene expression. 
Immunofluorescence staining showed constitutive nuclear localization of the NF-κB 
subunit p65 in absence of stimulation after CHC knockdown. Elevated basal p65 nuclear 
localization is caused by constitutive phosphorylation and degradation of inhibitor of NF-
κB (IκBα) through an IκBα kinase α (IKKα)-dependent mechanism. The role of CHC in 
NF-κB signaling is functionally relevant as constitutive expression of the proinflammatory 
chemokine interleukin-8 (IL-8), whose expression is regulated by NF-κB, was found after 
CHC knockdown. Disruption of clathrin-mediated endocytosis by depletion of the μ2-
subunit of the endocytosis adaptor protein AP-2 and knockdown of clathrin light chain a 
(CHLa), failed to induce constitutive NF-κB activation and IL-8 expression, showing that 
CHC acts on NF-κB independently of endocytosis and CLCa.  
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Conclusions: We conclude that CHC functions as a built-in molecular brake that ensures a 
tight control of basal NF-κB activation and gene expression in unstimulated cells. 
Furthermore, our data suggest a potential link between a defect in CHC expression and 
chronic inflammation disorder and cancer.  
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3.2 INTRODUCTION 
 
Nuclear factor-kappa B (NF-κB) transcription factors control the expression of genes 
involved in a large spectrum of biological processes, including inflammation, adaptive 
immunity, stress responses, angiogenesis, cell proliferation and invasion (Basseres and 
Baldwin 2006; Hayden, West et al. 2006). Aberrant regulation of NF-κB activity has been 
associated with immune disorders and numerous cancers (Prasad, Ravindran et al.). 
Although NF-κB has been the subject of intensive investigation, the molecular mechanisms 
underlying its regulation are not fully understood. There are five NF-κB isoforms in 
mammalian cells: p65/RelA, RelB, c-Rel, p50 (NF-κB1) and p52 (NF-κB2). All these 
proteins share a Rel homology domain responsible for homo- and heterodimerization as 
well as for sequence-specific DNA binding. Among the various hetero-and homodimers 
formed by NF-κB proteins, the p50/p65 heterodimer is predominant in many cell types 
(Baldwin 1996). Dimers of NF-κB proteins bind κB sites in promoters or enhancers of 
target genes and regulate transcription via the recruitment of transcriptional co-activators 
and co-repressors. A number of posttranslational modifications of the NF-κB proteins, 
including phosphorylations and acetylations, further modulate DNA binding and, therefore, 
transcriptional activity (Perkins 2006). In absence of stimulation, most of the NF-κB 
dimers are retained in the cytoplasm by the Inhibitor of NF-κB (IκB) family members 
whose prototype is the protein IκBα (Baeuerle and Baltimore 1988; Beg and Baldwin 
1993; Baldwin 1996). IκBα contains several ankyrin repeats that mediate the binding to 
NF-κB dimers and mask the nuclear localization signal (NLS) of p65. Following cell 
stimulation by proinflammatory cytokines, such as tumor necrosis factor α (TNFα) and 
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interleukin-1, IκBα is rapidly phosphorylated on serine 32 and serine 36 residues by the 
IκB kinase (IKK) complex composed of three subunits: two catalytic subunits, IKKα and 
IKKβ, and the regulatory scaffold component NF-κB essential modulator (NEMO). IκBα 
phosphorylation is then followed by rapid polyubiquitination and degradation via the 26S 
proteasome. Released NF-κB dimers translocate into the nucleus where they drive gene 
expression (Gilmore 2006; Hayden and Ghosh 2008). As the gene encoding IκBα is 
rapidly upregulated following NF-κB activation, IκBα is promptly resynthesized 
(Hoffmann, Levchenko et al. 2002). Newly synthesized IκBα proteins bind to nuclear NF-
κB dimers and dissociate them from DNA. This mechanism terminates the transcriptional 
activity of NF-κB and resets gene expression to basal level.  
 Although constitutive NF-κB activation has been associated with 
inflammatory disorders and numerous cancers (Prasad, Ravindran et al. ; Yamaguchi, Ito et 
al. 2009), the mechanisms leading to elevated basal NF-κB activation remain unclear. 
Proposed mechanisms include activation of kinases, overexpression of cytokines, 
dysregulation of cell surface receptors and activation of oncoproteins. We recently 
performed an RNA interference (RNAi) screen targeting host signaling proteins that could 
potentially be involved in the inflammatory response following infection by Shigella 
flexneri (Kim et al., submitted). From that screen, we identified clathrin heavy chain (CHC) 
as one of the proteins that, when knocked down, strongly enhanced activation of NF-κB. In 
this study, we examine the role of CHC in the control of basal NF-κB activation.  
 CHC is mainly known as a structural component of clathrin and for its role in 
clathrin-mediated endocytosis (CME) (Royle 2006; Miaczynska and Stenmark 2008). The 
association of three CHCs and up to three clathrin light chains (CLCs) forms a clathrin 
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triskelion structure that self-polymerizes to form a curved lattice around invaginated pits.  
Through this mechanism, CHC is involved in the uptake of nutrients, the internalization of 
pathogens, the downregulation of certain ligand-induced receptors and in protein sorting at 
the trans-Golgi network (TGN) during protein secretion (Conner and Schmid 2003; Veiga 
and Cossart 2005; Miaczynska and Stenmark 2008). However, similar to other endocytic 
proteins (Pilecka, Banach-Orlowska et al. 2007), CHC appears to perform multiple 
functions in cells. It has been reported that CHC is involved in chromosome segregation 
during mitosis (Royle, Bright et al. 2005). In addition, a fraction of CHC proteins that 
localize to the nucleus bind to the p53-responsive promoter and favor p53-mediated 
transcription (Enari, Ohmori et al. 2006).  
 Here we have used RNAi to effectively knock down CHC in epithelial cells. 
Surprisingly, we found that the depletion of CHC induces constitutive nuclear localization 
of the NF-κB subunit p65 in absence of stimulation. Elevated basal p65 nuclear 
localization was associated with constitutive phosphorylation and degradation of IκBα via 
an IKKα dependent mechanism and constitutive expression of the proinflammatory 
chemokine interleukin-8 (IL-8), whose expression is regulated by NF-κB. Interestingly, 
CHC acted on NF-κB independently from its roles in CME and from CLCs. Taken together, 
our data reveal a new function of CHC in the control of basal NF-κB activity and gene 
expression in epithelial cells.  
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3.3 MATERIALS AND METHODS 
 
Antibodies and reagents 
Antibodies against NF-κB p65, IκBα, CLCa and IKKα were obtained from Santa Cruz 
Biotechnology (Santa Cruz, USA) while the anti-CHC antibody was from BD Transduction 
Laboratories (San Jose, USA). The anti-actin antibody was from Chemicon (Billerica, 
USA) and the anti-phospho-IκBα was from Cell signaling technology (Beverly, USA). The 
anti-mouse IgG-Cy5 was obtained from Zymed (San Francisco, USA) and the anti-rabbit 
IgG-HRP and anti-mouse IgG-HRP from GE Healthcare (Pittsburgh, USA). Hoeschst and 
FITC-phalloidin were from Invitrogen (Carlsbad, USA). 
 
Cell culture and siRNA transfection 
HeLa Kyoto (Neumann, Held et al. 2006) and MCF-7 cells (ATCC, Manassas, USA) were 
maintained in Dulbecco’s modified Eagle’s medium (high glucose) supplemented with 
10% fetal bovine serum, 100 units/ml penicillin, and 100 μg/ml streptomycin at 37 °C in 
10% CO2. HeLa and MCF-7 cells were transfected with different siRNAs at 10 nM using 
Lipofectamine 2000 (Invitrogen, Carlsbad, USA). ON-TARGETplus SMARTpool siRNAs 
for clathrin heavy chain (CHC/CLTC, #L-004001-00-005), clathrin light chain a 
(CLCa/CLTA, #L-004002-00-005), AP2M1 (#L-008170-00-005), IKKα (#L-003473-00-
005) and ON-TARGETplus siCONTROL were obtained from Dharmacon (Dallas, USA). 
 
Immunofluorescence and microscopy 
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Cells were fixed with 4% PFA for 6 min and permeabilized in 0.5% Triton X-100 for 10 
min. They were, then, incubated with a mouse monoclonal anti-p65 antibody (1 μg/ml) 
overnight at 4 °C and stained with a Cy5-conjugated secondary antibody and Hoechst (10 
μg/ml) for 40 min at room temperature. Images were acquired at 12 random sites of each 
well using the automated ImageXpress microscope (Molecular devices, Sunnyvale, USA). 
The nuclear localization of p65 was automatically quantified by using the Enhanced-
Translocation module of MetaXpress (Molecular devices, Sunnyvale, USA). Briefly, the 
Hoechst staining was used as a mask to automatically identify nuclei in the p65 staining 
image. The cytoplasmic area of each cell was defined by a ring around the nucleus. For 
each cell, the ratio of p65 intensity in the nucleus and in the cytoplasmic ring defined as the 
Nuc/Cyt p65 NF-κB ratio was calculated and averaged over several thousands of cells per 
well.  
 
Transferrin uptake assay 
Transferrin uptake was measured as described by Galvez T. et al (Galvez, Teruel et al. 
2007). Briefly, HeLa cells were treated with Alexa 594-conjugated transferrin (Invitrogen) 
for 10 min followed by a quick acid wash to cleave off the receptor-bound transferrin from 
the plasma membrane. Cells were then fixed with 4% PFA and stained with Hoechst. 
Transferrin uptake was automatically quantified by using the Multi-wave Length Cell 
Scoring module of MetaXpress (Molecular devices, Sunnyvale, USA).  
 
Enzyme- linked Immunosorbent Assay (ELISA) 
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IL-8 secretion was measured by ELISA in the supernatant of siRNA-transfected HeLa and 
MCF-7 cells, 72 hours post transfection. Cell-free supernatants from triplicate wells were 
analyzed for their IL-8 content using a commercial ELISA kit (BD Pharmingen, San Jose, 
USA). In parallel, cells from the plate were stained with Hoechst to quantify cell numbers. 
IL-8 measurements were normalized to the number of cells for each condition. 
 
Western Blot Analysis 
HeLa or MCF-7 cells were transfected with siRNAs in a 6-well plate. 72 hours post 
transfection, cells were lysed in Phosphosafe Extraction Buffer (Novagen, Darmstadt, 
Germany) supplemented with 1x protease inhibitor cocktail (Calbiochem, Darmstadt, 
Germany). Protein concentration was measured using the bicinchoninic acid (BCA) kit 
(Pierce, Rockford, USA). Equal amounts of proteins were resolved by SDS-PAGE and 
transferred to Hybond C-Extra membrane (Amersham Bioscience, Pittsburgh, USA) for 
immunoblotting with indicated antibodies. Primary antibodies were detected using 
horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG antibodies, and visualized 
with the ECL system (Pierce). Quantification of the blots was performed using the 
densitometry feature of Photoshop.  
 
Quantitative real-time PCR 
Total RNA was isolated from control or CHC siRNA transfected cells in a 6-well plate 
using the total RNA purification system (Invitrogen, Carlsbad, USA). cDNAs were 
generated by  using the Superscript III 1st Strand Synthesis Kit (Invitrogen, Carlsbad, 
USA). Real-time PCR was performed on an ABI Prism 7700 system (Applied Biosystems, 
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Foster city, USA) using the SYBR green PCR Master Mix (Applied Biosystems, Foster 
city, USA) to measure relative IκBα mRNA level in CHC-depleted and control cells. 
GAPDH was used as an internal control to normalize mRNA expression. Each sample was 
analyzed in triplicate. The primer sequences used are as follows. IκBα-forward: 5’-
GACCTGGTGTCACTCCTGTTG; IκBα-reverse: 5’-
CTCTCCTCATCCTCACTCTCTGG; GAPDH-forward: 5’-GAAGGTGAAGGTCG 
GAGTC; GAPDH-reverse: 5’-GAAGATGGTGATGGGATTTC.  
 
Statistical analysis 
Results are expressed as the mean ± SD as specified in figure legends. p values were 
calculated with a two-tailed two-sample equal variance t-test. p values of less than 0.05 
were considered statistically significant.  
 73
CHAPTER 3   CHC regulation of basal NF-κB activation 
3.4 RESULTS 
 
3.4.1 CHC prevents constitutive NF-κB p65 nuclear localization in unstimulated 
epithelial cells  
To investigate the implication of CHC in the regulation of basal NF-κB activation, we 
tested whether CHC interfered with the localization of the NF-κB subunit p65 in absence 
of stimulation. For this purpose, HeLa cells were depleted of CHC by transfection with a 
pool of four siRNAs targeting CHC. A pool of four none-targeting siRNAs was used as 
control in parallel. The efficiency of knockdown after 72 hours was controlled by 
measuring the expression of CHC by western immunoblotting (Figure 3.1A). The 
localization of p65 was visualized by immunofluorescence microscopy with an anti-p65 
antibody. As expected, p65 was mostly present in the cytoplasm of control cells (Figure 
3.1B, left panel). Surprisingly, both cytoplasmic and nuclear localization of p65 was 
observed after CHC knockdown (Figure 3.1B, right panel). This observation was 
confirmed by quantification with automated image processing of the nuclear/cytoplasmic 
p65 intensity ratio (Figure 3.1C). These results showed that CHC expression is required to 
prevent constitutive nuclear localization of p65 in unstimulated HeLa cells.  
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Figure 3.1 CHC prevents constitutive NF-κB p65 nuclear localization in unstimulated 
epithelial cells.  
(A) Effective knockdown of CHC after siRNA transfection. Lysates from HeLa cells transfected 
with control (Ctrl) or CHC siRNAs for 72 hours were analyzed by western immunoblotting using 
the indicated antibodies. Actin is shown as a loading control. (B) Constitutive nuclear localization 
of p65 after CHC knockdown. HeLa cells were transfected with either control or CHC siRNA and 
p65 localization was visualized by immunofluorescence microscopy. White arrows indicate cells 
showing a clear nuclear localization of p65. Scale bars, 10 μm. (C) Quantification of the 
nuclear/cytosolic p65 intensity ratio in control and CHC siRNA transfected HeLa cells (results are 
expressed as the mean ± SD of 12 images; *p=3.14E-07, graph representative of 3 independent 
experiments).  
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3.4.2 CHC prevents constitutive IKK-mediated phosphorylation and degradation of 
IκBα in unstimulated epithelial cells 
The localization of p65 results from a complex equilibrium between cytoplasm to nucleus 
translocation and nuclear export (Hoffmann, Levchenko et al. 2002). We analyzed, most 
specifically, the implication of CHC in the mechanisms that control the nuclear 
translocation of p65. In the canonical NF-κB activation pathway triggered by most stimuli, 
this process is tightly controlled by IKK complex-dependent phosphorylation and 
proteolytic degradation of IκB proteins. As we observed more p65 in the nuclei of CHC-
depleted cells, we hypothesized that basal IκB degradation was elevated in these cells. To 
directly test this assumption, the level of IκBα in CHC and control siRNA transfected cells 
was analyzed by western immunoblotting. As shown in Figure 3.2A, a strong reduction in 
the level of IκBα was found after CHC knockdown. To exclude the hypothesis that this 
diminution resulted from reduced IκBα gene transcription, the level of IκBα mRNA was 
analyzed by quantitative real-time PCR. A two-fold increase in IκBα mRNA was measured 
after knockdown compared to control (Figure 3.2B), indicating that the reduction of IκBα 
level was not caused by an inhibition of transcription but, most likely, by constitutive 
degradation of IκBα proteins. Because the catalytic subunit IKKα largely contributes to 
IκBα phosphorylation and degradation in HeLa cells (Adli, Merkhofer et al.), we examined 
the effect of IKKα knockdown on constitutive IκBα degradation. For this purpose, HeLa 
cells were transfected with combinations of CHC and IKKα siRNAs for single or co-
depletion experiments as described in Figure 3.2C. When IKKα was depleted, the 
knockdown of CHC had no effect on the level of IκBα (Figure 3.2C), showing that CHC 
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controls basal IκBα degradation by a mechanism dependent on IKKα. ΙκΒα proteins are 
subject to phosphorylation by the IKK complex prior to degradation. Therefore we tested if 
constitutive IκBα degradation resulted from an increase of IκBα phosphorylation (p-IκBα). 
The phosphorylation at position serine 32 was analyzed by western immunoblotting using a 
phospho-specific antibody. Interestingly, a two-fold increase in the level of p-IκBα was 
observed in CHC-depleted cells (Figures 3.2D and 3.2E) after normalization to the level of 
IκBα, suggesting that constitutive degradation of IκBα was caused by constitutive IκBα 
phosphorylation. Taken together, these results showed that CHC prevents constitutive NF-
κB activation in unstimulated HeLa cells by blocking the spontaneous phosphorylation and 
degradation of IκBα by the IKK complex.  
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Figure 3.2 CHC prevents constitutive degradation and phosphorylation of IκBα by an IKKα-
dependent mechanism.  
(A) Reduced level of IκBα after CHC knockdown in HeLa cells. Cell lysates from control or CHC 
siRNA transfected cells were analyzed by western immunoblotting using the indicated antibodies. 
Actin is shown as a loading control (representative of 3 independent experiments). (B) 
Quantification of the level of IκBα mRNA by quantitative RT-PCR in control or CHC-depleted 
HeLa cells. GAPDH mRNA was used as an internal control for normalization (results are expressed 
as the mean ± SD of 3 independent experiments). (C) IKKα-depletion abolishes the constitutive 
degradation of IκBα induced by CHC knockdown. Lysates from cells transfected with different 
combinations of IKKα and CHC siRNAs were analyzed by immunoblotting using the indicated 
antibodies. Total siRNA concentration was kept constant by adding appropriate amounts of control 
siRNAs. Actin is shown as a loading control (data representative of 2 independent experiments). 
(D) CHC prevents enhanced basal phosphorylation of IκBα at position serine 32.  Lysates from 
control or CHC-depleted HeLa cells were analyzed by immunoblotting using the indicated 
antibodies. Actin is shown as a loading control. (E) Densitometric quantification of the p-
IκBα/IκBα ratio (results are expressed as the mean ± SD of 3 independent experiments).  
 
 
3.4.3 CHC prevents constitutive IL-8 secretion in unstimulated epithelial cells 
Previous results indicated that CHC was required to prevent constitutive p65 
nuclear translocation. Because this process directly contributes to the regulation of gene 
expression, we tested whether the presence of CHC was also necessary to prevent 
constitutive expression of genes regulated by NF-κB. In particular, we investigated the 
expression of the proinflammatory chemokine IL-8. IL-8 secretion was measured by 
ELISA in the supernatant of CHC and control siRNA transfected HeLa cells. In line with 
the results obtained on NF-κB activation, knocking down CHC strongly enhanced basal IL-
8 secretion (Figure 3.3A), showing that, indeed, the expression of CHC was critical to 
prevent constitutive IL-8 expression in HeLa cells. The same result was obtained in the 
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breast cancer cell line MCF-7 (Figure 3.3B). Furthermore, consistent with the results 
obtained on IκBα degradation, constitutive expression of IL-8 was massively reduced 
when IKKα was knocked down (Figure 3.3C). Taken together, these results showed that 
CHC prevents constitutive expression of IL-8, and that this new function of CHC in NF-κB 
signaling depends on IKKα and corresponds to a general mechanism taking place in 
different cells lines.  
 
Figure 3.3 CHC prevents constitutive IL-8 expression in unstimulated epithelial cells 
(A) Constitutive IL-8 expression after knockdown of CHC in HeLa cells. Cells were transfected 
with control or CHC siRNAs. After 72 hours, supernatants were collected and analyzed for their 
content in IL-8 by ELISA (results are expressed as the mean ± SD of 3 independent experiments). 
(B)  Constitutive IL-8 expression after knockdown of CHC in MCF-7 cells. MCF-7 cells were 
treated as described in (A) (results are expressed as the mean ± SD of 3 independent experiments). 
(C) IKKα-depletion abolishes the constitutive secretion of IL-8 induced by CHC knockdown. HeLa 
cells were transfected with different combinations of IKKα and CHC siRNAs for 72 hours. Total 
siRNA concentration was kept constant by adding appropriate amounts of control siRNAs. 
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Supernatants were collected to measure the concentration of IL-8 by ELISA (results are expressed 
as the mean ± SD of 3 independent experiments).  
 
 
3.4.4 CHC controls basal NF-κB activation independently of endocytosis and clathrin 
light chains  
Through its activity in CME, CHC is involved in the internalization of nutrients, 
pathogens, antigens, growth factors and receptors (Conner and Schmid 2003; Veiga and 
Cossart 2005; Miaczynska and Stenmark 2008). To test whether CHC regulated indirectly 
the NF-κB pathway via its function in CME, we measured p65 nuclear translocation and 
IL-8 secretion in cells where CME was disrupted by RNAi-mediated depletion of the μ2-
subunit of the main CME adaptor protein AP-2 (AP2M1). The recruitment of AP-2 at the 
plasma membrane is critical for the initiation of CME (Motley, Bright et al. 2003). AP-2 
interacts with sorting signals present in the cytoplasmic domains of membrane proteins 
destined to become cargo in the coated vesicles. In addition, AP-2 recruits clathrin onto the 
membrane, where it functions as a scaffold for vesicle budding. First, in order to 
demonstrate that CME was impaired in AP2M1 and CHC-depleted cells, the CME-
dependent mechanism of transferrin uptake was monitored in HeLa cells. As previously 
reported (Motley, Bright et al. 2003), depletion of both CHC and AP2M1 impaired the 
uptake of fluorescently labeled transferrin (Figures 3.4A and 3.4B). However, although the 
depletion of AP2M1 blocked transferrin uptake to the same extent as CHC knockdown, it 
failed to increase basal IκBα degradation (Figures 3.4C and 3.4D) and IL-8 secretion 
(Figure 3.4E), indicating that CHC controls basal NF-κB activation and gene expression 
independently of its activity in CME.  
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CHC is associated to CLCs in clathrin triskelion structures. The functional roles of 
CLCs have been recently characterized using RNAi. Knocking down CLCs has no effect 
on CME or the formation of clathrin-coated pits (Poupon, Girard et al. 2008). However, it 
causes alterations in protein trafficking at the TGN resulting from disruption of huntingtin 
interacting protein 1 related (HIPR1) recruitment to clathrin-coated structures and 
disorganization of the actin cytoskeleton (Poupon, Girard et al. 2008). Since CLCs are 
unstable unless they are bound to CHC (Hinrichsen, Harborth et al. 2003), we tested 
whether the effect of CHC depletion on NF-κB activation was indirectly due to CLC 
degradation. For this purpose, IκBα degradation and IL-8 secretion were analyzed in HeLa 
cells depleted of the protein clathrin light chain a (CLCa) by RNAi. Although the degree of 
CLCa depletion detected by western immunoblotting was similar in cells transfected with 
CHC and CLCa siRNAs (Figure 3.4F), knocking down CLCa failed to induce constitutive 
IκBα degradation (Figures 3.4F and 3.4G) and IL-8 secretion (Figure 3.4H). These results 
showed that the effects of CHC depletion on NF-κB signaling were directly caused by the 
depletion of CHC and not by the associated depletion of CLCa. Taken together, these 
results strongly indicated that CHC prevents constitutive NF-κB activation independently 
of endocytosis and clathrin light chains.  
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Figure 3.4 CHC regulates NF-κB activation independently of endocytosis and CLCa.  
(A) Uptake of Alexa 594-transferrin (Alexa 594-Tf) in cells transfected with control (left panels), 
AP2M1 (middle panels) or CHC (right panels) siRNAs. Scale bars, 10 μm (B) Quantification of 
transferrin uptake by automated image analysis (results are expressed as the mean ± SD of 12 
images; graph representative of 2 independent experiments). (C) AP2M1 knockdown fails to 
enhance IκBα degradation. Cell lysates from control, AP2M1 or CHC siRNA-transfected cells 
were analyzed by immunoblotting using indicated antibodies. Actin is shown as a loading control. 
(D) Densitometric quantification of the levels of IκBα shown in Figure 3.4C (graph representative 
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of 2 independent experiments). (E) AP2M1 knockdown fails to induce constitutive IL-8 expression. 
HeLa cells were transfected with control, AP2M1 or CHC siRNAs for 72 hours. Supernatants were 
collected to measure the concentration of IL-8 by ELISA (results are expressed as the mean ± SD of 
3 independent experiments). (F) CLCa knockdown fails to enhance IκBα degradation. Cell lysates 
from control, CLCa or CHC siRNA transfected cells were analyzed by immunoblotting using 
indicated antibodies. Actin is shown as loading control.  (G) Densitometric quantification of IκBα 
levels shown in Figure 3.4F (Graph representative of 2 independent experiments). (H) CLCa 
knockdown fails to induce constitutive IL-8 expression. HeLa cells were transfected with control, 
CLCa or CHC siRNAs for 72 hours and supernatants were collected to measure the concentration 
of IL-8 by ELISA (results are expressed as the mean ± SD of 3 independent experiments).  
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3.5 DISCUSSION 
 
Most research groups investigating the regulation of NF-κB activation have focused 
their studies on the mechanisms induced after cell exposure to various stimuli, including 
inflammatory cytokines and microbial products. In particular, the canonical pathway of 
NF-κB activation that depends on the phosphorylation and degradation of IκB proteins 
downstream of the activation of the IKK complex has been well characterized. In contrast, 
although constitutive NF-κB activation has been associated with inflammatory disorders 
and numerous cancers (Prasad, Ravindran et al. ; Yamaguchi, Ito et al. 2009), the 
mechanisms that lead to elevated basal NF-κB activation remain unclear.  
Here we show that CHC functions as a built-in molecular brake that ensures a tight 
control of basal NF-κB activation and gene expression by preventing constitutive nuclear 
localization of p65 in absence of stimulation. Using RNAi to reduce cellular levels of CHC, 
we found that CHC is required for the proper spatial regulation of p65 in unstimulated 
epithelial cells. Whereas p65 was almost exclusively localized in the cytoplasm of control 
cells, both cytoplasmic and nuclear localization was observed in cells depleted of CHC. 
The localization of p65 is largely dependent on IκB proteins that sequestrate the 
transcription factor in the cytoplasm. Genetic deletion or mutations of IκBα lead to 
constitutive nuclear localization and NF-κB activation (Beg, Sha et al. 1995; Yamaguchi, 
Ito et al. 2009). In line with these studies, we found that the effect of CHC depletion on p65 
was associated with a strong reduction in the level of IκBα, suggesting that constitutive 
p65 nuclear localization was likely due to reduced IκBα level. Quantification of IκBα 
mRNA by quantitative real time PCR revealed that the level of IκBα mRNA was slightly 
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elevated in CHC depleted cells. This result, which can be explained by the fact that IκBα is 
a target gene of NF-κB that is upregulated by constitutive NF-κB activation, indicated that 
the reduction of IκBα found in CHC depleted cells, was not due to transcriptional 
inhibition but to elevated basal IκBα degradation. This hypothesis was further supported 
by data showing that the knockdown of CHC induced constitutive phosphorylation of IκBα 
at position 32, a phosphorylation event critical to target IκBα for rapid degradation via the 
ubiquitin proteasome pathway. The role of CHC in the control of basal NF-κB activation 
was functionally relevant. Indeed a strong induction of IL-8, whose expression is controlled 
by NF-κB, was observed in cells depleted of CHC showing that, via its activity on NF-κB, 
CHC participates to gene regulation. Interestingly, a role of CHC in p53-mediated 
transcription has been recently reported. Enari et al. showed that a fraction of CHC proteins 
that localize to the nucleus bind to p53-responsive promoters and favor transcription by 
stabilizing p53 interactions with proteins such as the histone acetyltransferase p300 (Enari, 
Ohmori et al. 2006). Although CHC contributes to p53 and NF-κB-regulated gene 
expression by different mechanisms, our data provide a second set of evidence for a role of 
CHC in gene regulation.  
Via its role in CME, CHC is involved in many cellular processes including 
intracellular trafficking of receptors and nutrient uptake (Miaczynska and Stenmark 2008). 
To investigate whether CHC indirectly affected basal NF-κB activation via its implication 
in CME, we analyzed the level of IκBα and IL-8 expression in conditions where CME was 
disrupted by the depletion of the μ2-subunit of the main CME adaptor AP-2. Whereas the 
CME-dependent process of transferrin uptake was almost completely abolished, AP2M1 
depletion had no effect on the NF-κB signaling pathway, suggesting that CHC was 
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involved in the NF-κB pathway independently of endocytosis. Although we cannot 
completely rule out the contribution of a CME mechanism independent of AP-2, these 
results provide strong evidence for an endocytosis-independent function of CHC in NF-κB-
mediated gene regulation. As CLCs are unstable unless bound to CHC, the knockdown of 
CHC is associated with cellular depletion of CLCs. Interestingly, we showed that the 
depletion of CLCa has no effect on IκBα degradation and IL-8 expression, indicating that 
CHC alone contributes to the regulation of the NF-κB pathway. It also suggested that CHC 
functions in this pathway independently of the roles that CHC and CLCa share in protein 
trafficking at the TGN (Poupon, Girard et al. 2008).  
A raising number of proteins involved at different levels of the signaling pathway 
contribute to the tight control of basal NF-κB activation in resting cells (Prasad, Ravindran 
et al.). For instance, expression of the tumor suppressor Gprc5a prevents constitutive p65 
nuclear localization and NF-κB activation (Deng, Fujimoto et al.). Although the 
mechanism remains unclear, the authors propose that the presence of Gprc5a may promote 
the stabilizing interaction between β-arrestin and IκBα. The role of silencer of death 
domain (SODD) has also been reported (Jiang, Woronicz et al. 1999). SODD deficiency 
leads to an increase of NF-κB activation and cytokine expression in absence of stimulation. 
This protein functions as a gatekeeper that constitutively associates with the cytoplasmic 
death domain of TNF receptors (TNFR) and blocks TNFR signaling in the absence of 
ligand. Constitutive activity of NF-κB was also described in c-Abl null fibroblasts 
(Liberatore, Goff et al. 2009). In contrast to previous mechanisms, unstimulated fibroblasts 
did not exhibit an increase in IκBα degradation or p65 nuclear translocation but reduced 
levels of the negative regulator histone deacetylase HDAC1. The mechanism by which 
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CHC functions in NF-κB signaling remains to be elucidated. Based on our data, we 
propose that this protein acts as a built-in molecular break that prevents the spontaneous 
activation of the IKK complex. This hypothesis is supported by the observation that 
constitutive IκBα degradation and IL-8 secretion were almost completely abolished when 
IKKα was depleted, and that IκBα was enhanced after CHC knockdown. Because the 
localization of IKKs is critical for their activity (Weil, Schwamborn et al. 2003), the 
implication of CHC in the sub-cellular distribution of the IKK complex should be further 
investigated.  
We also report here that CHC impedes constitutive IL-8 secretion by unstimulated 
HeLa and MCF-7 cells. It is well established that constitutive IL-8 secretion by epithelial 
cells can lead to chronic recruitment of macrophages that produce and secrete into the 
microenvironement a variety of cytokines, chemokines and growth factors involved in 
inflammation-related diseases such as inflammatory bowel disease. In addition, some of 
these factors promote angiogenesis and act directly on epithelial cells to favor adenoma 
formation and progression to adenocarcinomas (Basseres and Baldwin 2006). Therefore by 
showing that CHC prevents constitutive expression of the proinflammatory and 
tumorigenic factor IL-8, our data suggest that alterations in CHC expression may be 
associated with chronic inflammation disorder or cancer. As a consequence, CHC 
expression, that can be regulated by external stimuli such as androgens (Prescott and 
Tindall 1998), should be systematically investigated in tumors and inflamed tissues.  
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CONCLUSIONS AND OUTLOOK  
Role of IKKα in inflammation and innate immunity  
Pro-inflammatory cytokines such as TNFα and IL-1, and many pathogens 
including S. flexneri activate the transcription factor NF-κB via the so-called canonical 
pathways, which results in the expression of chemokines such as IL-8, one of the key 
mediators in inflammation and innate immunity (Akira, Uematsu et al. 2006; Lawrence 
2009). Ample evidence indicates that in the canonical NF-κB pathways IKKβ subunit 
of the IKK complex is essential for phosphorylation and degradation of IκBα, causing it 
to dissociate from NF-κB and allowing NF-κB to translocate to the nucleus, whereas 
IKKα subunit regulates the non-canonical or alternative pathway important for B-cell 
maturation and lymphoid organogenesis rather than inflammation and innate immunity 
(Karin and Ben-Neriah 2000; Bonizzi and Karin 2004; Dejardin 2006; Lawrence and 
Bebien 2007). In contrast to this dominant model of IKKβ-dependent NF-κB activation 
in the canonical pathways, we have shown here for the first time that IKKα also 
regulates the canonical NF-κB activation and subsequent IL-8 expression downstream 
of Nod1-mediated peptidoglycan recognition during S. flexneri infection of HeLa cells. 
A very recent study also shows that both IKKα and IKKβ contribute to IκBα 
phosphorylation and NF-κB activation in response to TNFα stimulation in HeLa cells 
(Adli, Merkhofer et al. 2010), supporting the role of IKKα in the canonical NF-κB 
activation. Therefore, it is conceivable that IKKα as well as IKKβ plays an essential 
role in inflammation and innate immunity. However, it still remains an open question as 
to how IKKα and IKKβ stay as an inactive complex in resting cells and gets rapidly 
activated upon stimulation.  
Mechanism of IKKα activation 
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A putative model for the activation of IKKα and IKKβ is their activation loop 
(T-loop) phosphorylation in the N-terminal kinase domain by upstream kinases such as 
TAK1 (Hayden and Ghosh 2008). Thus, mutation of the serine residues (S176/S180 for 
IKKα and S177/S181 for IKKβ) in the T-loop to alanines abrogates NF-κB activation in 
response to TNFα stimulation (Hacker and Karin 2006). However, different from the 
TNFR signaling, phosphorylation at the two serine residues was barely detectable in 
response to S.flexneri infection or Tri-DAP treatment up to 60 minutes when IκBα 
degradation occurs maximally (unpublished data), suggesting that Nod1-mediated NF-
κB activation might be independent of the T-loop phosphorylation of IKKα and IKKβ. 
This may further indicate that the serine residues in the T-loop of IKKα and IKKβ may 
be structurally required for NF-κB activation but the serines phosphorylation may not 
be functionally responsible for IκBα phosphorylation since IκBα phosphorylation and 
degradation occurs in the absence of IKK phosphorylation upon S.flexneri infection or 
Nod1 stimulation. A study showed that in addition to phosphorylation of two serine 
residues in the T-loop, phosphorylation of two tyrosine residues (Y187/Y198 for IKKα 
and Y188/Y199 for IKKβ) is induced by protein kinase C-dependent c-Src activation 
and is important for TNFα-induced NF-κB activation and subsequent target gene 
expression (Huang, Chen et al. 2003; Huang, Chen et al. 2003). Tyrosine 
phosphorylation of IKKα and IKKβ in the Nod1 signaling pathways is yet unknown. In 
an independent study, we observed that S.flexneri infection or Tri-DAP treatment of 
HeLa cells induced strong tyrosine phosphorylation of multiple undefined proteins, 
which is detected by both immnofluorescence  and western blot analysis using an anti-
phospho tyrosine (pY) antibody that specifically binds to tyrosine phosphorylated 
proteins (unpublished data). Given that Src is a tyrosine kinase known to be activated 
during Shigella entry process (Dehio, Prevost et al. 1995), it would be worth 
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investigating whether or not Src can induce tyrosine phosphorylation of IKKα and 
IKKβ during S.flexneri infection, and tyrosine phosphorylation of IKKα and IKKβ are 
responsible for NF-κB activation. 
IKKα and histone phosphorylation 
In addition to its activity toward IκBα phosphorylation, IKKα is involved in 
histone H3 phosphorylation, which facilitates NF-κB binding to IL-8 promoter 
(Yamamoto, Verma et al. 2003).  Previous studies showed that IL-8 is poorly secreted 
during S.flexneri infection in part due to the downregulation of host signalling by the 
Shigella type-III effectors (Arbibe, Kim et al. 2007; Zurawski, Mumy et al. 2009). 
Especially, the nucleus-targeted OspF dephosphorylates p38 and ERK, which are 
responsible for histone H3 Ser10 phosphorylation (Arbibe, Kim et al. 2007; Li, Xu et al. 
2007). Interestingly, I have recently found that IKKα and IKKβ phosphorylation at the 
two serine residues in the T-loop is induced not by wild type S.flexneri but by the 
OspF-deficient one (unpublished data). It will be of particular interest to study first of 
all, the previously unknown implication of S176/S180 phosphorylation of IKKα in the 
regulation of histone phosphorylation rather than IκBα phosphorylation and secondly, 
the unknown but possible connection between IKK and p38 (and ERK) as both are 
involved in histone H3 phosphorylation.  
In conclusion, this part of my thesis on IKKα not only shows the previously 
unknown function of IKKα in inflammation and innate immunity during bacterial 
infection but also may draw further attention for the IKKα-dependent NF-κB activation 
in many other canonical pathways. Furthermore, this finding may present new 
therapeutic opportunities for IKKα inhibitors in the treatment of infectious diseases. 
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Inhibition of basal NF-κB activation by clathrin heavy chain   
Constitutive NF-κB activation has been associated with many chronic 
inflammatory diseases such as cancer (Karin and Greten 2005), but the underlying 
molecular mechanism by which basal NF-κB is elevated remains unclear. I showed in 
the second part of my dissertation that depletion of clathrin heavy chain (CHC) resulted 
in constitutive IκBα degradation, NF-κB activation and high level of IL-8 secretion in 
resting cells. Normally, NF-κB is retained in the cytoplasm of resting cells through an 
interaction with IκBα, thereby preventing undesired activation of NF-κB (Liou and 
Baltimore 1993; Hayden and Ghosh 2008). Thus, genetic deletion of IκBα leads to 
constitutive NF-κB activation (Beg, Sha et al. 1995). However, unlike the constitutive 
NF-κB activation by genetic deletion of IκBα, which is simply due to the absence of 
IκBα expression that can bind to and retain NF-κB in the cytoplasm, CHC depletion 
induced higher mRNA expression of IκBα, indicating a constant turnover of IκBα at the 
post-translational level through an active event upstream of IκBα such as an activation 
of IKK complex.  
Inhibition of basal IKK activation and IκBα turnover by clathrin heavy chain   
Degradation of IκBα is induced by cytokines such as TNFα and bacterial 
products such Tri-DAP and is mediated by IKKα- and IKKβ-dependent 
phosphorylation and ubiquitin-proteasome pathway (Karin and Ben-Neriah 2000). A 
recent study shows that NLRC5, a member of NLR family inhibits the NF-κB 
signalling pathway by interacting with IKKα and IKKβ and blocking their 
phosphorylation after LPS stimulation (Cui, Zhu et al. 2010). Accordingly, depletion of 
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NLRC5 enhanced the activation of NF-κB and its responsive genes, TNFα and IL-6. 
Similarly, depletion of CHC enhanced the activation of NF-κB and the secretion of IL-8 
after S.flexneri infection or TNFα stimulation (data not shown). Although it is unclear 
whether CHC can also interact with and sequestrate the IKK complex in resting cells, 
depletion of IKKα drastically reduced CHC silencing-induced IκBα degradation and IL-
8 secretion, suggesting CHC depletion-induced NF-κB activation is also IKKα 
dependent. Thus, it is plausible that CHC might inhibit basal IKK activation via the 
interaction with the IKK complex or an upstream NF-κB regulator in resting cells. 
Inhibition of IKK activation by CHC-binding proteins   
Protein interaction studies have revealed several proteins of endocytic pathway 
that play additional functions as inhibitors of NF-κB signalling pathways. Tom1 (target 
of Myb1) interacts with CHC and Tollip (Toll-interacting protein), forming a complex 
regulating endocytosis of IL-1 receptor (IL-1R) (Yamakami, Yoshimori et al. 2003; 
Brissoni, Agostini et al. 2006). In addition, Tom1 inhibits NF-κB activation in the IL-
1R, TNFR, and TLR2/4 signalling pathways (Yamakami and Yokosawa 2004; Oglesby, 
Bray et al. 2010). Tollip forms a complex with IRAK (IL-1R-associated kinase) to 
block phosphorylation of IRAK, which prevents IKK and NF-κB activation upon 
stimulation of IL-1R (Burns, Clatworthy et al. 2000). However, functions of Tom1 and 
Tollip as inhibitors of NF-κB in resting cells were not clearly addressed in their studies. 
CHC interaction with and inhibition of IRAK in resting cells is unknown, but might be 
worth testing. A proteomics analysis designed to identify binding partners of CHC may 
help to understand the molecular mechanism by which CHC inhibits NF-κB activation 
in resting cells. In a proteomics analysis, IKAP (IκB kinase complex-associated protein) 
was identified as a component in the clathrin-containing vesicles although the physical 
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interaction between IKAP and clathrin was not tested (Borner, Harbour et al. 2006). An 
independent study showed that IKAP interacts with NIK and IKK complex and is a 
scaffold protein of the IKK complex (Cohen, Henzel et al. 1998). Whether IKAP and 
CHC interacts with each other and, if so, whether the interaction contributes to the 
regulation of NF-κB await further investigation. 
Endocytosis-independent functions of clathrin heavy chain   
Although NF-κB activation can be induced by many different mechanisms, little 
is known about the interconnection between endocytosis and regulation of NF-κB. 
Whether an inhibition of normal clathrin-mediated endocytosis (CME) can induce NF-
κB activation was examined. Our data showed that depletion of μ2 subunit of AP2 
complex (AP2M1) blocked transferrin-transferrin receptor internalization, a typical 
CME process, to a degree similar to CHC depletion, but failed to induce basal IκBα 
degradation and IL-8 secretion. This suggests that basal NF-κB activation by depletion 
of CHC was not merely attributed to the inhibition of endocytosis, and CHC might play 
an endocytosis-independent function as a negative regulator of NF-κB. However, we 
cannot rule out the possibility that the inhibition of CHC-dependent but AP2 complex-
independent endocytosis might be implicated in NF-κB activation. Some endocytosis-
independent functions were reported. A study showed that a small fraction of clathrin 
heavy chain (CHC) in the nucleus can contribute to the tumor suppressor p53-mediated 
gene expression by interacting with p53 and facilitating recruitment of transcriptional 
cofactors (Enari, Ohmori et al. 2006). Another study showed that CHC stabilizes 
spindle fibers to assist congression of chromosome during mitosis when endocytosis is 
in halt (Royle, Bright et al. 2005).  
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Although the exact action of CHC in the regulation of basal NF-κB activity 
remains to be further characterized, results presented in this dissertation suggest that 
CHC may play a new role as an inhibitor of NF-κB in resting cells, independently of 
endocytosis. Given the constitutive NF-κB activation and high level of IL-8 secretion 
by the depletion of CHC, CHC protein concentration might be an important factor in 
the regulation of basal IKK activity toward phosphorylation and degradation of IκB, 
further suggesting that a defect in CHC expression may be associated with chronic 
inflammatory disorders or cancers. 
Collectively, results presented in this dissertation highlight the complexity of 
NF-κB regulation far from being elucidated. Nevertheless, the RNAi technique must be 
appreciated in helping us reveal previously unknown functions of the well-characterized 
proteins, IKKα and CHC. A large scale functional genomics-approach like a genome-
wide RNAi screen will eventually help us better understand the complex NF-κB 
signalling network. 
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